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NEEDS AND HEALTH CARE UTILIZATION
P. Croft. Primary Care Sciences Research Centre, Keele
University, United Kingdom
There are a number of characteristics of osteoarthritis
which are important when considering its worldwide impact.
Firstly it is common, secondly it is ubiquitous, thirdly it
becomes increasingly common with age, and fourthly it
does not kill people. Although it is classified medically as a
pathological joint disease, which can be defined radiologi-
cally, it is the impact which the disease has on people’s
lives in terms of pain and restricted functioning, which
represents the practical problem.
The implication of the pain, as a symptom of chronic
condition, is the large consumption of analgesics and anti-
inflammatory drugs, together with their potential side effects
in the age group which are the highest users of such prepa-
rations. The second implication is the impact on health and
social services and on personal carers, which a condition
can have that restricts activity and is the main cause of
physical disablement in older people. As a society, the more
overweight and the less physically active are people who
enter their older years, the greater the subsequent level of
physical restriction and likely handicap in those who suffer
osteoarthritis. The third and most tangible impact on the
health services is represented by the need for joint replace-
ments. The wide range of the definition of need and the
increasing number of years for which implants might be
required to last, represent a potential acceleration in future
costs. However such costs must be balanced against
the effectiveness of such joint replacements in reducing
disability and the consequent economic advantages.
In this talk, estimates of the size of the need for different
types of health care will be presented, together with esti-
mates of the potential impact of primary and secondary
prevention on the clinical problem of osteoarthritis.
An optimistic view is that an increasing emphasis on
good preventive health measures (such as weight control
and physical activity), which are desirable for other rea-
sons, may help to keep in check the rising impact of
osteoarthritis on levels of physical functioning in the older
age groups. The pessimistic view would ask whether any
societies are demonstrating effective changes in this direc-
tion, at the same time as the consumption of analgesics
and the number of joint replacements continues to rise.MATRIX METALLOPROTEINASES IN
OSTEOARTHRITIS
Y. Okada. Department of Pathology, School of Medicine,
Keio University, Tokyo, Japan
Cartilage destruction in osteoarthritis (OA) is attributed
mainly to elevated proteinase activities on the basis of137imbalance to the endogenous inhibitors. Among protein
-ases, matrix metalloproteinases (MMPs) are considered to
play a major role in the degradation of many extracellular
matrix (ECM) components in the cartilage. MMPs are
composed of 18 different members and classified into 5
subgroups: collagenases (MMP-1, 8 and 13), gelatinases
(MMP-2 and 9), stromelysins (MMP-3 and 10), membrane
type MMPs (MT1, 2, 3, 4 and 5-MMPs) and others (MMP-7,
11, 12, 19, 20 and 23). Many groups including ours have
shown that several MMP species such as MMP-1, 2, 3, 7,
8, 9, 13 and MT1-MMP are expressed in OA cartilage. The
expression of most of these MMPs correlates with degree
of cartilage destruction evaluated by Mankin scores. MMPs
are, however, secreted in latent forms (proMMPs) and
activated extracellularly or pericellularly, while proMMP-11
and proMT-MMPs are activated intracellularly. We have
focused on the studies of the activation mechanisms of
proMMPs, and demonstrated that most secretive proMMPs
are activated by serine proteinases and active MMP-3. In
contrast, proMMP-2 can not be activated by serine protein-
ases, but efficiently activated on the cell membranes by
MT-MMPs. In OA cartilage, only proMMP-2 activation is
extensively studied. We have demonstrated that activation
ratio of proMMP-2 correlates directly with the MT1-MMP
expression in OA cartilage, and plasma membranes iso-
lated from chondrocytes and those directly isolated from
OA cartilage with MT1-MMP expression can activate
proMMP-2. Although MT1-MMP attacks the propeptide of
proMMP-2 to initiate the activation by an autocatalytic
mechanism, tissue inhibitor of metalloproteinases-2
(TIMP-2) is required for the efficient pericellular activation
by MT1-MMP. In addition, our biochemical studies indi-
cated that MT1-MMP is an ECM-degrading proteinase
capable of digesting interstitial collagens including type II
collagen, aggrecan, fibronectin, gelatins and laminin. MT1-
MMP cleaves the aggrecan G1–G2 domain at the Asn341-
Phe342 and Asp441-Leu442 and Gln354-Thr355 bonds, which
are different from those attacked by aggrecanase (ADMP-
1). Another important character of MT1-MMP is that its
activity is not inhibited by TIMP-1 but inhibited by TIMP-2
and TIMP-3. These data suggest that many MMPs
are implicated in the destruction of OA cartilage through
proteolytic degradation of the ECM components and
intermolecular activation of proMMPs.APOPTOSIS, MATRIX DEGRADATION AND
OSTEOARTHRITIS
M. W. Lark. SmithKline Beecham Pharmaceuticals, King of
Prussia, Pennsylvania, U.S.A.
Matrix metalloproteinases (MMPs) and aggrecanase have
been proposed to play a role in cartilage proteoglycan
catabolism in osteoarthritis (OA). MMPs are elevated in
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both MMP- and aggrecanase-generated matrix degrada-
tion products are found within OA cartilage. In addition to
cartilage matrix catabolism, there also appears to be an
elevation in chondrocyte apoptosis within OA cartilage, as
well as in cartilage from animal models of OA. There is
mounting evidence to suggest that there may be a relation-
ship between increased MMP expression, matrix degrada-
tion and apoptotic cell death. In vitro, there is an increase in
activity of the pro-apoptotic cysteine protease, caspase-3,
in chondrocytes undergoing apoptosis. Inhibitors of
caspase-3, prevent chondrocyte apoptosis in a dose-
dependent fashion in both cell and explant assays. In
addition, a novel member of the soluble frizzled-related
protein family, Frzb-2, has been identified and is expressed
by OA chondrocytes undergoing apoptosis. It is currently
unclear what role chondrocyte apoptosis plays in matrix
degradation although, under high impact loading conditions
in explant cultures, both chondrocyte apoptosis and prote-
oglycan loss is stimulated. These data suggest that
chondrocyte apoptosis and matrix degradation take place
under similar conditions and that there may be interplay
between these two processes to control cartilage matrix
homeostasis.CHARACTERISTICS OF CARTILAGE MATRIX
PROTEINS SHOWING ALTERED SYNTHESIS IN
OSTEOARTHRITIS
D. Heinega˚rd, P. Lorenzo and M. Bayliss*. Department of
Cell and Molecular Biology, Lund University, Lund,
Sweden, *Royal Veterinary College, London, U.K.
Cartilage extracellular matrix represents a composite
made up of a network of structural elements, ranging
from fibrils with a backbone of collagen II/XI to highly
anionic proteoglycans providing an extremely high fixed
charge density to the tissue. In joint disease the organiz-
ation of this matrix becomes progressively disturbed
by way of proteinase cleavage of structural elements.
Thus, early, preclinical, signs of osteoarthritis are an
increased thickness and altered surface organization of the
articular cartilage indicative of a malfunctioning collagen
network.
In studies of events at the molecular level at this com-
paratively early stage of cartilage disturbance, we have
found characteristic alterations in the synthetic pattern,
where particularly molecules like COMP, fibronectin and a
novel protein CILP show pronouncedly increased syn-
thesis. At the same time the levels of these proteins in
the tissue are increased, indicative of also increased
deposition of the proteins.
There is some information on functional properties of the
altered molecules. Thus COMP is a pentameric protein,
where a coiled coil domain close to the N-terminal end links
the 5 subunits that each contain a globular C-terminal
domain. Interestingly, this C-terminal domain can bind to
collagen in a Zn2+-dependent manner. The KD of the
interaction is about 10−9 and there are 4 apparently equal
sites on each collagen molecule distributed at each end
and at approximately 1/3 and 2/3 of the molecule. CILP is a
novel cartilage protein without significant homologies to
previously described proteins. Therefore the functional
properties of the protein are not known, but it shows a
restricted distribution to primarily the lower part of the
articular cartilage. It is particularly abundant in the
interterritorial matrix.It is of particular interest that also molecules like fibro-
modulin and decorin, that appear to have roles in the
homeostasis of the collagen network in tissues are
increased in articular cartilage where swelling indicates a
malfunction of this network. However, it appears that this
represents a synthetic response to previous degradation of
these proteins.
Thus, molecular changes in articular cartilage in joint
disease indicates increased degradation of tissue macro-
molecules as well as an increased biosynthesis of select
macromolecules, possibly representing a not well coordi-
nated repair attempt. It is noteworthy that e.g. the increased
synthesis and abundance of COMP is associated with
increased levels of COMP fragments in the circulation of
patients with active osteoarthritis.HUMAN ARTICULAR CHONDROCYTES AND
CARTILAGE HOMEOSTASIS
K. E. Kuettner. Rush Medical College, Chicago, IL, U.S.A.
The role of chondrocytes to govern and balance the syn-
thesis and degradation as well as the structure and inter-
action of its extracellular matrix (ECM) molecules in human
articular cartilage homeostasis remains unclear. We found
that chondrocytes in distinct layers from the articular sur-
face to the subchondral bone are metabolically different
(e.g. the selective synthesis and secretion of a unique
proteoglycan by superficial chondrocytes). Understanding
the role of the superficial chondrocyte in normal human
cartilage metabolism is extremely important since in oste-
oarthritis (OA) the earliest damage occurs in the superficial
layer. OA develops through dynamic changes in ECM
turnover, either via degradation of ECM molecules or
through changes in rate of synthesis and/or structure of
ECM components. The chondrocytes try to replenish lost
ECM components, reflecting an attempted, but gradually
failing repair, ultimately leading to an inadequate articular
cartilage. Loss of ECM is based on a process called
chondrocytic chondrolysis, whereby select matrix metallo-
proteases (MMPs) degrade and/or fragment the ECM com-
ponents (e.g. fibronectin, collagen and hyaluronan). OA is a
non-inflammatory disease with rare inflammatory episodes.
Our studies with human articular chondrocytes from donor
tissues indicate that these fragments may be the driving
force for ECM destruction similar to the action of catabolic
cytokines. On the other hand, anabolic mediators such as
IGF-I and osteogenic proteins (OPs) may also play a role in
cartilage homeostasis. OP-1 has been purified from bone
matrix, and is capable of cartilage induction as well as bone
formation. We have demonstrated that human articular
chondrocytes express OP-1 endogenously. The expression
of OP-1 mRNA is up-regulated in OA cartilage compared to
normal cartilages from newborn and adult donors. The
expression of mature OP-1 protein in OA tissues is down-
regulated, while the level of pro-OP-1 remains high as
confirmed by immunohistochemistry and Western blotting
on cartilage extracts. Mature OP-1 is primarily detected in
the superficial layer, and the pro-form in the deep layer
suggesting that OP-1 may control and/or prevent cartilage
from degeneration and possibly initiate tissue repair. In
addition to differences between superficial and deep
condrocytes in human articular cartilage, we have been
able to document differences between the condrocytes
obtained from different joints. The prevalence of OA is
much lower in the ankle than in the knee joint. We
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adult donors (matched pairs). Only normal cartilages
are included in this study. The data from 100 donor
cartilages suggest that there are differences in cartilage
metabolism, biochemical composition and biomechanical
properties between the two joints. Metabolic studies have
focused on the response of chondrocytes to catabolic
stimuli, either interleukin-1 or fibronectin-fragments. With
both stimuli, chondrocytes decrease matrix synthesis,
increase MMP synthesis as well as matrix degradation.
However, the condrocytes from the knee respond to lower
doses than chondrocytes from the ankle. Comparisons
of the biochemical composition of the two cartilages
showed that the ankle cartilage had a higher proteoglycan
and collagen and a lower water content. The dynamic
stiffness was higher in the ankle than in the knee,
while hydraulic permeability was lower. The data emerging
from these continuing studies confirm that there are
significant differences between the cartilages of the
two joints that could help to explain their differences in
susceptibility to OA.PHYSICAL REGULATION OF CHONDROCYTE
METABOLISM IN NORMAL AND INJURED
CARTILAGE
A. Grodzinsky, P. Ragan, M. Jin, A. Loening, M. Levenston
and E. Frank. Dept Electrical Engineering, Center for
Biomedical Engineering, Massachusetts Institute of
Technology, Cambridge, MA, U.S.A. 02139
Cartilage matrix adaptation to biomechanical demands in
health and disease is enabled by the ability of chondrocytes
to sense and respond to physical stimuli. Recent studies
suggest that there are multiple regulatory pathways (e.g.,
upstream signalling, transcription, translation, and post-
translational modifications by which chondrocytes respond
to mechanical stimuli and thereby alter the quantity and
quality of newly synthesized extracellular matrix macromol-
ecules. For example, mechanical compression can alter
the size, sulfation, and chain length of chondroitin sulfate
(CS) glycosaminoglycans and their spacing along the
newly synthesized aggrecan core protein. The microstruc-
tural properties of these matrix molecules and their appro-
priate assembly in the ECM are critical determinants of
cartilage’s biomechanical properties.
The mechanisms by which chondrocytes respond to
mechanical loads are difficult to study in vivo. As a result,
in vitro models such as cartilage explants and 3-D chondro-
cyte gel culture systems have become increasingly import-
ant. Dynamic tissue shear and dynamic axial compression
can both stimulate proteoglycan and protein synthesis.
Recent studies have shown that both static and dynamic
compression of chondrocytes in intact tissue explants and
in alginate gel culture can alter the expression of aggrecan
and type II collagen mRNA. Results suggest that the
stability of the mRNA is not affected by loading; further-
more, the effects of compression on matrix biosynthesis do
not appear to be regulated solely by changes in mRNA
levels induced by compression. For example, the dramatic
changes in the morphology and volume/surface densities
of intracellular organelles induced by static compression
may also regulate the processing and structure of
molecules such as aggrecan.
Mechanical loading associated with joint cartilage injury
is also a risk factor for development of OA. Studies in vitrohave shown that injurious mechanical compression can
cause an increase in the number of apoptotic cells on
cartilage in a dose dependent manner. Apoptotic cell
death can be induced at loading levels below the threshold
that produced changes in GAG release, tissue swelling,
and matrix biomechanical properties. The observation
that apoptosis precedes these other changes in the
ECM suggests that this could be one of the earliest
events in response to cartilage injury. The possibility that
chondrocytes from different joint cartilages (such as that
from knee and ankle tissues) respond differently to static,
dynamic, and injurious mechanical compression is under
study.
Funded in part by NIH Grants AR33236 and AR45779.GROWTH FACTORS AND MORPHOGENS IN
CARTILAGE AND MATRIX REPAIR
F. P. Luyten. University Hospitals KU Leuven, Leuven,
Belgium
Joint damage and loss of function result from the imbalance
between breakdown and the reparative capacity of joint
tissues. While many efforts have been made to understand
the processes leading to tissue breakdown, little is known
on the molecular mechanisms driving the maintenance of
the integrity of the joint surface and its repair. Increasing
evidence indicates that the signals leading to embryonic
tissue formation are also involved in the reparative
responses postnatally. Therefore, we have focused our
research efforts on the developmental cascades leading to
the formation of the skeletal structures and the synovial
joints.
The last decade has been characterized by the
discovery of several signaling pathways critical in skeletal
embryonic development, including skeletal patterning,
joint morphogenesis, and cartilage and bone differentiation
and maturation. One of the most significant breakthroughs
in this area was the isolation and cloning of the
Bone Morphogenetic Proteins (BMPs), members of
the TGF- superfamily. The BMPs were originally
identified as protein fractions in demineralized bone
matrix extracts, capable of inducing in vivo de novo endo-
chondral bone formation. Subsequent homology cloning
led to the identification of a large family of related
BMPs, including the Growth and Differentiation factors
(GDFs) and the Cartilage-derived Morphogenetic Proteins
(CDMPs). Expression analysis and genetic studies
confirmed the critical role of these signaling pathways
in the formation of the mouse and human skeleton and the
joints.
Interestingly and not surprisingly, several BMPs are
present and secreted in postnatal cartilage, joint associated
tissues and bone. Both in vitro and in vivo studies indicate
that they may play a pivotal role in the maintenance and
repair of these tissues. For instance, overexpression/
addition of specific BMPs promotes chondrogenesis and
cartilage differentiation, while loss of function/suppression
studies results in matrix depletion and joint disorders remi-
niscent of osteoarthrosis. The existing data clearly demon-
strates that the study of these skeletal developmental
pathways has identified new opportunities to enhance
repair processes and define potential novel therapeutic
targets in joint diseases.
140 AbstractsCARTILAGE REPAIR IN ANIMAL MODELS: WHAT
HAVE WE LEARNED?
Ernst B. Hunziker. M. E. Mu¨ller Institute for Biomechanics,
University of Bern, Switzerland
Articular cartilage lesions are a very commonly encoun-
tered problem, for which there exists no satisfactory solu-
tion at present. Although many treatment protocols are in
current clinical use, but few of these have achieved this
status as a result of rigorous evaluations in experimental
animals. Such appraisals require not only the selection of a
suitable animal species, but also a careful consideration of
the defect parameters in relation to the biological setting
and of the relevance of the chosen model to the human
situation. In this presentation, the basic biological require-
ments that need to be satisfied for successful repair of
partial-thickness defects in articular cartilage tissue will be
outlined, emphasis being placed on the needs in humans
and how these can be best simulated in animal models so
as to yield data of clinical value. The importance of employ-
ing a space-defining matrix in treatment strategies will be
stressed and the requisite properties of such implants
delineated. Pitfalls associated with the surgical suturing of
tissue flaps to defect sites will also be pointed out. The
exigency of taking steps to ensure optimal integration
between native- and repair-tissue compartments will be
dealt with and the measures that can be adopted to achieve
this end detailed. With respect to full-thickness articular
cartilage defect models, potential approaches for optimiz-
ing tissue-compartment-specific repair results, including
the barrier principle, will be discussed.CARTILAGE REPAIR: AN UPDATE ON THE CLINICAL
EXPERIENCE
Mats Brittberg. Cartilage Research Unit, Go¨teborg
University, Go¨teborg, Sweden
Articular cartilage has only a limited capacity for repair after
injury and there is still no clinical repair technique that
has been completely successful in producing a complete
cartilage regeneration.
All current clinical cartilage repair methods could be
regarded as different types of cell therapies. Most common
method to treat cartilage defects is still a bonemarrow
stimulation with drilling, abrasion arthroplasty or microfrac-
turing, allowing stem cells to migrate into the defect and to
populate the fibrin clot. The resulting repair tissue is fibro-
cartilaginous in character. Periostal and perichondral graft-
ing in combination with subchondral drilling have been
reported to produce hyalinelike repair through recruitment
chondrogeneic cells from the bone marrow and the graft
itself. However, in a few recent human long-term follow-ups
between 6–9 years post-surgery both periosteal and peri-
chondral grafts deteriorated in a high percentage. In the
reports from the perichondral graftings there were a high
percentage of mineralization of the grafts which partly may
explain those failures. Large experience exist with osteo-
chondral allografting and interesting is also the multiple
autologous osteochondral grafting technique recently intro-
ducing clinically. Transplantation of in vitro expanded
autologous chondrocytes in combination with periosteal
grafting has been tried for chondral and osteochondral
lesions of human knees with promising results. In the near
future in vitro expanded mesenchymal chondrogenic stem
cells could be an alternative cell type to be used for clinical
articular resurfacing.Unfortunately, there are a lack of randomized studies
comparing the natural history of cartilage injuries to differ-
ent cartilage repair methods and yet we are not able to
conclude which method that is superior to produce a repair
tissue with the potential to heal the injured cartilage and
maintain its function over prolonged periods. To date, a
variety of articular cartilage resurfacing techniques have
the potential to improve the repair of cartilage defects,
reduce the patients disability. Theoretically, articular carti-
lage resurfacing may also prevent the progression of a
local cartilage defect into osteoarthritis, but still we do not
know if levelling out a chondral defect will prevent such a
development. Hopefully, with a steadily increased co-
operation between basic and clinical sciences we may in
the future be able to achieve a reliable restoration of the
injured cartilage; from the small defect to the widespread
cartilage loss of osteoarthritis.A FEMALE-SPECIFIC SUSCEPTIBILITY GENE FOR
IDIOPATHIC OSTEOARTHRITIS IS LOCATED ON
CHROMOSOME 11q
J. Loughlin, K. Chapman, Z. Mustafa, A. Smith, C. Irven, A.
Carr and B. Sykes. University of Oxford, Institute of
Molecular Medicine and Nuffield Orthopaedic Centre,
Oxford, United Kingdom
We have performed a two-stage genome-wide scan for
osteoarthritis (OA) susceptibility loci using 481 families that
each contain at least one affected sibling pair. The first
stage of 272 microsatellite markers and 297 families
involved a sparse map covering 23 chromosomes at inter-
vals of approximately 15 cM. Sixteen markers that had
evidence of linkage at nominal P≤0.05 were than taken
through to the second stage using an additional 184
families. This second stage confirmed evidence of linkage
for markers on chromosome 11q. Additional markers from
this region were then typed creating a denser map. We
obtained a maximum single-point LOD score at D11S901 of
2.40 (P=0.0004) and a maximum multipoint LOD score
(MLS) of 3.15 between markers D11S1358 and D11S35. A
subset of 196 of the 481 families comprising affected
female sibling pairs generated a corrected LOD score of
2.54 (P=0.0003) for marker D11S901 with evidence for
linkage extending 12 cM proximal to this marker. An MLS of
2.81 for female-only pairs was obtained between markers
D11S901 and D11S1342. When we stratified for affected
male sibling pairs there was no evidence of linkage to
chromosome 11. Our data suggested that a female-specific
susceptibility gene for idiopathic osteoarthritis is located on
chromosome 11q.PHYSICAL AND TRANSCRIPTION MAP OF THE
CANDIDATE INTERVAL FOR FAMILIAL
CHONDROCALCINOSIS AT CHROMOSOME 5p15.1
K. Rojas1, L. Serrano de la Pen˜a1, T. Gallardo2, A.
Simmons2, E. Peterson3, D. Grady3, K. Nyce1, E. Considine1,
R. Cox4, L. J. Andrew4, M. Lovett2, J. Overhauser1 and C. J.
Williams1. 1Thomas Jefferson University, Philadelphia, PA,
U.S.A.; 2Southwestern Medical Center, Dallas, TX, U.S.A.;
3Los Alamos National Laboratory, Los Alamos, NM, U.S.A.;
4Wellcome Trust Centre for Human Genetics, Oxford
University, Headington, Oxford, U.K.
Aim of the study To generate a physical and transcription
map of the familial chondrocalcinosis candidate gene
interval residing on chromosome 5p.
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markers in an around the chondrocalcinosis interval were
used to identify a yeast artificial chromosome clone that
spanned the candidate interval. This clone provided a low
resolution framework upon which other clones, including
bacterial artificial chromosomes (BACs) and P1 artificial
chromosomes (PACs), were aligned with respect to the
polymorphic and EST markers. A high resolution cosmid
contig of the interval was then constructed by screening a
chromosome 5-arrayed cosmid library with the same
markers and with the BAC and PAC clones. Gaps in the
contig were filled by cosmid walking and, where necessary,
by subcloning all or part of the BACs that encompassed
regions with gaps. Additional ESTs from GeneMap98, as
well as several novel cDNA transcripts recovered by direct
selection, were mapped on the cosmid contig.
Results The completed cosmid contig spans an interval
of approximately 0.4 Mbp and includes 0.15 Mbp of the
refined chondrocalcinosis interval demarcated by the radia-
tion hybrid marker stSG3654 and the polymorphic marker
D5S2114. Two candidate genes were identified in the
refined interval: one transcript was approximately 6.8 Kbp
in size, was expressed in skeletal muscle, and, by RT-PCR
analysis, was also expressed in adult articular cartilage and
in synovium. A second expressed sequence with a tran-
script size of 2.4 Kbp was detected primarily in liver. By
RT-PCR analysis it, too, was expressed in adult articular
cartilage and synovium. Both of these candidate interval
transcripts were recovered by direct cDNA selection and
correspond to ESTs reported in GeneMap98. Neither tran-
script showed any homology to any gene in public data-
bases. A third transcript, which resided just telomeric to the
chondrocalcinosis candidate interval, presumably codes for
the human homologue of bovine myosin X. Myosin X
contains an ATP binding domain and calcium binding
domains in the N-terminal end of the transcript, thus
making it an attractive candidate gene. Since it is possible
that the 5′ end of the human homologue of myosin X
extends into the candidate interval, we are cloning this end
of the human transcript to more precisely map it on the
cosmid contig.
Conclusions The purpose of constructing a physical map
of the chondrocalcinosis interval is to aid in the identifica-
tion of potential causative genes for the familial form of this
disorder. Genetic mapping has enabled us to refine the
interval to approximately 150,000 bp and the physical and
transcription map has identified 3 potential transcripts that
may be considered candidate genes for the disorder. We
are now in the process of completing the full-length cDNA
sequences for each of these transcripts. Ultimately, these
cDNAs will be subjected to mutational analyses in order to
identify the genetic defect in familial chondrocalcinosis.CHANGES IN CHONDROCYTE-SPECIFIC GENE
EXPRESSION PATTERNS DURING LOSS OF THE
CHONDROCYTE-SPECIFIC PHENOTYPE AND ITS
SUBSEQUENT RECOVERY
D. G. Stokes, G. Liu, R. Dharmavaram and S. A. Jiminez.
Division of Rheumatology, Department of Medicine,
Jefferson Medical College, Thomas Jefferson University,
Philadelphia, Pennsylvania, U.S.A.
Chondrocytes are highly specialized cells that are respon-
sible for the production and assembly of the abundant
extracellular matrix of all cartilaginous tissues including
articular cartilage. During ex vivo growth of chondrocytesas monolayer cultures they proliferate and undergo a
process termed de-differentiation. This process involves
a change in morphology from a spherical cell shape to a
more flattened spread-out cell shape and also a change
in the gene expression pattern from expression of
chondrocyte-specific genes such as types II, IX, and XI
collagen from aggrecan to genes that are normally associ-
ated with fibroblasts including types I and III collagen and
versican. Upon transfer of the monolayer cultured chondro-
cyte to a more three-dimensional culture system, such as
culture on polyhydroxyethyl methacrylate hydrogels (poly-
HEMA), agarose, alginate, or certain artificial scaffolds,
the cell slows its proliferation and can reacquire its
chondrocyte-phenotype, or re-differentiate, and produce
a cartilaginous-like tissue in vitro. We have performed
an investigation into the reversibility of the chondrocyte
phenotype by culturing human epiphyseal chondrocytes
on tissue culture plastic for multiple passages followed
by re-plating on polyHEMA coated dishes. As assayed by
morphology, RT-PCR of chondrocyte-specific gene expres-
sion and chondrocyte-specific promoter activity, we show
that in this system the chondrocytes can reacquire their
chondrocyte-specific phenotype after 8 weeks and 2 pas-
sages in monolayer. Interestingly, the activity of a reporter
construct containing the promoter and enhancer from the
human COL2A1 gene was modulated by the culture con-
ditions in that its transcriptional activity was repressed in
monolayer and rescued to some extent when the cells were
switched to polyHEMA. We are currently attempting to
determine whether addition of certain growth factors will
enhance the ability of de-differentiated chondrocytes from
monolayer cultures to revert and recover their chondrocyte-
specific phenotype when transferred to polyHEMA coated
dishes and whether other chondrocyte-specific gene pro-
moters respond in the same way. Supported by NIH grant
P01AR39740.DO RADIOGRAPHIC PATTERNS OF HIP OA
INFLUENCE THE GENETIC PREDISPOSITION
AMONGST FAMILY MEMBERS
P. Lanyon, S. Doherty, K. Muir* and M. Doherty. Rheuma-
tology Unit, City Hospital and *Queen’s Medical Centre,
Nottingham, U.K.
Aims We have recently reported a strong genetic
influence on the development of hip OA, based on a study
of 604 siblings of 392 index cases who had undergone THR
for hip OA.1 The aim of this study was to determine whether
this genetic predisposition in siblings is influenced by the
pattern of radiographic changes in the index case and
whether specific patterns ‘breed true’ within families.
Methods Subjects comprised 513 siblings (298 female,
215 male, mean age 66 years) of 336 index THR cases
whose preoperative pelvic X-rays were available. Minimum
joint space (MJS) was measured by metered caliper to
0.1 mm, osteophyte graded according to the OARS atlas,2
and the site of femoral head migration designated as either
indeterminate, superolateral, axial or medial. Hip OA was
defined according to a MJS of either ≤2.5 mm (probable) or
≤1.5 mm (definite).3 Siblings were subgrouped according to
both the site of femoral head migration and the absence
(grade 0) or presence (grades 1–3) of osteophyte response
in their index case. Age-adjusted relative risks of hip OA in
siblings were calculated in comparison to a group of 1806
subjects who had undergone intravenous urography, see
Table I. The site of femoral head migration was compared
142 AbstractsConclusion The genetic influence on the development of
hip OA is significantly greater amongst those families in
which the index case has no bone response. Patterns of
femoral head migration do not breed true, suggesting that
whilst the tendency to develop hip OA is under strong
genetic influence, interaction between genetic and environ-
mental or mechanical factors may be more important in
determining the specific phenotype.References
1. Arthritis Rheum 1998;41 (9 Suppl).
2. Osteoarthritis Cart 1995;3:3–70.
3. Am J Epidemiol 1990;132:514–22.STATIC LOADING CAN ALTER TUMOUR NECROSIS
FACTOR RECEPTOR EXPRESSION ON
CHONDROCYTES FROM OSTEOARTHRITIC
CARTILAGE
C. I. Westacott and C. J. Elson. University of Bristol, Bristol,
U.K.
Introduction Previous work shows regional differences in
cartilage susceptibility to the effects of tumour necrosis
factor alpha (TNF) are closely related to expression of the
biologically active p55 TNFreceptor(R). Thus focal loss of
cartilage will occur in the presence of sufficient TNF only
in those regions where chondrocytes are susceptible to
its effects. In osteoarthritic (OA) knees, cartilage is lost
from region of peak loading. The purpose of this work
was therefore to determine whether chondrocyte TNF-Rexpression can be upregulated by simulated mechanical
loading.
Methods and materials OA cartilage was obtained from
the knee joints of patients undergoing surgery for total knee
replacement (n=6, age 63±8.4 years). Non-arthritic (NA)
cartilage was obtained from the femoral heads of patients
(n=5, age 80±9.6 years) undergoing surgery for total hip
replacement following fracture of the femoral neck.
Chondrocytes were isolated by overnight enzymatic diges-
tion at 37°C harvested, encapsulated in alginate and beads
(4×105 chondrocytes/bead) incubated in DMEM/Hams
(24 h, 37°C) before use. Beads were placed in Eppendorf
tubes (10/tube) and subjected to speeds calculated to
represent loads of 20, 10, 5, or 3 MPa for various intervals
of time up to 1 h. After further incubation at 37°C for
between 2 and 54 h, chondrocytes were released from
alginate by incubation in sodium citrate. Chondrocytes
were harvested, stained using specific monoclonal anti-
bodies and TNF-R expression analysed by flow cytometry.
TNF-R expression on cells subjected to load was com-
pared with that on unloaded controls at each time point.
Results Centrifugation of encapsulated OA chondrocytes
for 1 h at speeds calculated to represent 20 MPa markedly
altered chondrocyte p55 TNF-R expression. Comparison of
chondrocytes subjected to such load with unloaded con-
trols showed an 8-fold increase in p55 TNF-R expression at
2–4 h and again at 24–48 h after centrifugation. By con-
trast, p75 TNF-R expression was unchanged. Sensitivity of
chondrocytes to the effects of loading varied between
preparations. On average, exposure of OA chondrocytes to
lower centrifugation speeds for shorter periods reduced the
effect on p55 TNF-R expression. By contrast, exposure of
NA chondrocytes to 20 MPa for 1 h resulted in decreased
p55 TNF-R expression. Exposure to lower pressures for
shorter time periods similarly decreased chondrocyte p55
TNF-R expression. However, p75 TNF-R expression
increased at lower pressures on chondrocytes from some
NA preparations.
Conclusion TNF-R expression on OA, but not NA,
chondrocytes, is increased by pressures representing high
physiological loads. If OA chondrocyte TNF-R expression is
similarly increased in vivo, these results suggest a mech-
anism by which sensitivity to TNF could be increased in
regions of peak loading.DO THE BIOMECHANICAL PROPERTIES OF
ARTICULAR CARTILAGE CORRELATE WITH THE
HISTOLOGICAL STAGE OF DEGRADATION? A
CADAVERIC STUDY
T. Franz1, E. M. Hasler2, R. Hagg3, C. Weiler1, W. Mu¨ller3,
R. P. Jakob1, T. Schaffner4 and P. Mainil-Varlet4. 1Depart-
ment of Orthopedic Surgery, Hoˆpital cantonal Fribourg,
Fribourg, Switzerland; 2Biomechanics & 3Biotech Depart-
ment, Sulzer Orthopedics Ltd, Winterthur, Switzerland;
4Department of Pathology, University of Berne, Berne,
Switzerland
Aim of the study Degeneration of articular cartilage is
accompanied by changes in the structure and composition
of the tissue leading to a reduction in cartilage compressive
stiffness. With the current interest in cartilage repair there is
a need to diagnose cartilage disorders at an early stage.
Moreover, the properties of cartilage should be monitored
quantitatively rather than subjectively by palpating the
surface with a blunt probe. The aim of this study is to
investigate possible correlations between the structure, thein index cases and their affected siblings (MJS of ≤2.5 mm)
see Table II.
Results:Table I
Relative risk in siblings (95% C.I.) according to definition
Index pattern MJS≤2.5 mm MJS≤1.5 mm
Superolateral 4.84 (3.50, 6.70) 5.28 (3.34, 8.35)
Axial 5.29 (3.56, 7.80) 7.75 (4.70, 12.9)
Indeterminate 4.18 (2.31, 7.56) 6.71 (3.24, 13.8)
Medial 4.20 (1.85, 9.49) 6.14 (2.32, 16.2)
Osteophyte 0 5.72 (3.42, 9.59) 11.61 (6.32, 21.3)
Osteophyte 1–3 4.73 (3.61, 6.20) 5.59 (3.81, 8.21)
The risk of definite OA is doubled for those siblings whose index
cases had no osteophyte response compared to those with any
degree of osteophyte (P=0.019).Table II
Site of maximum narrowing in index case N, (%) within index case
Site in sibling Indeterminate Superolateral Axial Medial
Indeterminate 2 (2.7) 3 (7.0) 1 (14.3)
Superolateral 5 (41.7) 19 (26.0) 12 (27.9) 2 (28.6)
Axial 7 (58.3) 52 (71.2) 28 (65.1) 4 (57.1)
Total 12 73 43 7
No correlation is seen between the pattern of femoral head
migration in affected siblings and their index cases, even after
adjusting for the effects of age and sex.
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cartilage measured in situ with an indentation device that
can be used intraoperatively.
Methods Using a hand-held indentation device (ArtscanY),
cartilage compressive stiffness was measured on 24 right
knees from fresh human cadavers (age: 32–89 years,
mean 65 years). Measurements were performed on the
medial (MPG) and the lateral (LPG) facet of the patellar
groove and the weight bearing areas of the medial (MFC)
and the lateral (LFC) femoral condyle. Only sites with
macroscopically normal or a sightly fibrillated surface were
assessed. The indenter (Ø 1 mm) imposed a short (1 s),
constant (0.3 mm) deformation on the cartilage surface and
the resistive force of the cartilage was measured. The
compressive stiffness of articular cartilage can be repre-
sented by the instant shear modulus derived from the
measured force and the geometry of indentation according
to the elastic model developed by Hayes et al., 1972.
Immediately after biomechanical testing, two osteochondral
plugs for biochemical and histological evaluation were
harvested from each location and the cartilage thickness
was ascertained using a magnifying lens. Biochemical
analysis included determination of total proteoglycan
(PG) and total collagen content. The stage of cartilage
degeneration was assessed according to Mankin’s
histological-histochemical grading score.
Results The instant shear modulus varied with location
and was higher in the femoral condyles than in the patellar
groove (Table I). There was a significant correlation
between instant shear modulus and histological grading
score at each location (data for MFC are shown in Fig. 1).However, no correlation was apparent between instant
shear modulus and total PG or total collagen content (data
not shown).
Conclusions In the present study we did not see a corre-
lation between cartilage compressive stiffness and the total
PG content or the total collagen content. There was,
however, a significant correlation between the biomechani-
cal measurement and the structural integrity of articular
cartilage, represented by the histological appearance. We
conclude, that the short term compressive stiffness of
articular cartilage depends on the integrity of the collagen
network (surface integrity, crosslinks, etc.) and not on the
total amount of PG or collagen. While current methods ofin situ cartilage evaluation rely usually on subjective grad-
ing, this indentation device provides quantitative stiffness
data which appear to correlate with the structural integrity
of articular cartilage. Thus, the indentation device may be
used to detect early cartilage degeneration and allows to
monitor cartilage integrity during the repair process.
Disclaimer The authors have not received anything of
value from a commercial or other party related directly or
indirectly to the subject of presentation.CARTILAGE COLLAGEN CHANGES IN
OSTEOARTHRITIS
K. von der Mark, T. Aigner, S. Riemer and J. Weisser.
Friedrich-Alexander University, Erlangen- Nuremberg,
Germany
In-situ hybridization analysis and metabolic labeling exper-
iments indicate focal, but significantly enhanced expression
of type II collagen in the upper middle zone of osteoarthritic,
original articular cartilage in early stages of the disease. It is
followed by the appearance of type III collagen in the upper,
fibrillated zone showing loss of proteoglycans, while little
type I collagen is found. Throughout the articular cartilage
type VI collagen is also enhanced, particularly in the
pericellular space. Clusters of hypertrophic chondrocytes
expressing type X collagen appear in the deep zone above
the fading tide mark and become exposed to the surface
with progressing erosion of cartilage in later phases of the
diseases. Since type X collagen is not found in healthy
articular cartilage above the tidemark, we were interested
in factors stimulating or preventing chondrocyte hypertro-
phy and type X collagen expression in OA cartilage.
There is ample evidence in the literature that one of the
major factors preventing chondrocyte maturation and
hypertrophy is PTHrP which stimulates proliferation and
delays differentiation of chondrocytes in the growth plate.
Both PTH and PTHrP have been shown to inhibit type X
collagen expression. In order to elucidate this mechanism,
chondrocytes from fetal bovine growth plates were incu-
bated under serum-free conditions with various PTH and
PTH peptides. PTH, PTHrP and PTH (1–34), but not PTH
(3–34) suppressed type X collagen mRNA levels by 80%,
indicating that these domains activate the adenylate
cyclase pathway of the PTH/PTHrP receptor. Blocking of
PKC by bis-indolylmaleimide did not affect the suppressive
effect of PTH (1–34). In contrast, PTH (28–48) as well as
PTH (52–84) stimulated type X collagen expression; PTH
(52–84) also enhanced intracellular Ca+ + levels in hyper-
trophic chondrocytes by activating the receptor for the
c-terminal domain of PTH.
In order to elucidate whether the observed PTH effects
on type X collagen expression are regulated at transcrip-
tional level, transient transfection experiments were per-
formed with chondrocytes from the hypertrophic and the
resting zone in the presence of PTH-peptides. PTH (1–34)
suppressed transcription of reporter genes containing
2.5 kb of the human type X collagen promoter which
included a tissue-specific enhancer site. In contrast, PTH
(28–48) enhanced transcription of the ColX promoter con-
struct containing the enhancer site. Thyroid hormone T3
which has been shown to stimulate type X collagen syn-
thesis in chondrocyte cultures (Bo¨hme et al., 1992) also
stimulated transcription of the 2.5 kb COL10A1 reporter
gene and increased type X collagen mRNA levels in
hypertrophic chondrocytes.
In order to get insight into the differential response of
chondrocytes to PTH peptides at various differentiationTable I
Pooled data for all subjects and each location
Location, N Thickness (mm) Shear mod. (MPa)
Mean SEM Mean SEM
LPG N=24 2.2 0.11 3.13 0.21
MPH N=23 2.2 0.18 2.23 0.19
LFC N=24 2.5 0.15 3.22 0.19
MFC N=22 2.0 0.16 3.34 0.33
144 Abstractsstages, growth plate chondrocytes were fractionated in a
linear percoll gradient, yielding 4 distinct chondrocyte popu-
lations with clear differences in size, density and gene
expression pattern (fractions B1–B4). As expected, highest
levels of type X collagen mRNA were found in the hyper-
trophic fractions B1 and B2, but interestingly these fractions
also contained highest levels of the PTH/PTHrP-receptor.
PTH (1–34) and PTHrP (1–40) significantly suppressed
type X collagen and indian hedgehog (Ihh) levels in these
fractions. In fractions B1 and B3 the levels of PTHrP
receptor mRNA could be stimulated 2 fold by PTH (28–34)
and PTH (52–84). These studies demonstrate a differential
and antagonistic regulation of chondrocyte maturation
and type X collagen expression by different domains of
PTH and PTHrP, mediated by different PTH receptors.ATP RELEASE BY MECHANICALLY LOADED
CHONDRONS IN PELLET CULTURE
R. D. Graff, E. R. Lazarowski, A. J. Banes and G. M. Lee.
University of North Carolina, Chapel Hill, NC, U.S.A.
ATP in cartilage functions as a pharmacological mediator of
matrix turnover and as a substrate for the generation of
pyrophosphate (PPi) which can lead to CPPD crystal
formation in crystal deposition diseases. The source of
extracellular ATP in cartilage has not been reported, but it
has been thought to derive from damaged cells. We have
examined the release of ATP by porcine chondrons in pellet
culture at rest and during cyclic compression. Chondrons
were isolated from porcine articular cartilage by enzymatic
digestion and maintained in pellet cultures after centrifu-
gation in V-bottom 96-well culture plates. Culture media
(Opti-MEM supplemented with 2% FBS, 25 g/ml
ascorbate-2-PO4) were refreshed every 48 h for 6 days and
after weaning to serum-free (SF) media, pellets maintained
in 6 ml culture tubes in SF media for an additional 1–2
weeks. Dynamic compression was performed with 2–3-
week-old pellets using a Compression PlusY device (Flex-
cell Intl Corp.). ATP accumulation in culture media was
measured using a firefly luciferase assay. Cell viability was
measured using an MTT assay (Sigma). Measurement of
endogenous ATP in media of resting cultures indicated that
ATP was continuously released to maintain a baseline
concentration of approximately 2–4 nM. Cyclic compres-
sion resulted in a further release that reached maximal at
5–15 min and declined thereafter to baseline within 60 min.
ATP release increased with applied pressure (3–15 kPa),
but in all cases ATP fell to baseline concentrations within
60 min despite continued loading. Cultures cyclically com-
pressed for 60 min at 7.5 kPa could again be induced to
release ATP, but only with elevated pressure (15 kPa). This
second peak of ATP release (8.0±1.1 nM at 15 kPa) was
less than half the release observed in cultures loaded at
15 kPa for the first time (22.5±1.3 nM) suggesting chondro-
cyte desensitization to load. MTT assays showed no differ-
ence in cell viability between pellets at rest or up to 24 h
after cyclic compression. A regulated membrane transport
mechanism for nucleotide release rather than cell injury
was indicated by inhibition of ATP release by 0.5 mM
octanol. The decline in ATP concentration was due to the
activity of one or more pyrophosphohydrolase enzymes, as
evidenced by the accumulation of pyrophosphate (32PPi)
but not inorganic phosphate (32Pi), in resting cultures
incubated with 32P-ATP. The occurrence of baseline ATP
concentrations despite the pressure of active ATPppase
suggests that ATP is continuously released by chondro-cytes at rest and that the rate of ATP release is dramatically
increased by mechanical loading. Together these data
suggest a role for ATP in normal chondrocyte cell signaling
and in the pathogenesis of OA. (Supported by NIAMS
AR43883 and a Glaxo Wellcome/UNC Collaborative
Research Agreement.)NITRIC OXIDE PRODUCTION AND CHONDROCYTE
APOPTOSIS IN HUMAN OSTEOARTHRITIC
CARTILAGE
H. Inoue, K. Nishida, M. Matsuo, T. Doi, H. Kato, N. Shiota
and A. Yoshida. Department of Orthopaedic Surgery,
Okayama University Medical School, Okayama, Japan
Introduction There are increasing evidences that
chondrocyte apoptosis plays an important role in cartilage
development, aging and disease. Recent study strongly
suggest that inducible nitric oxide synthase (iNOS), synthe-
sized by osteoarthritic (OA) chondrocytes in response to
inflammatoric cytokines such as IL-1, TNF-, or lipopoly-
saccharides catalyses formation of nitric oxide (NO). The
present study was aimed to investigate the role of NO on
chondrocyte apoptosis in the progression of OA cartilage
breakdown.
Materials and Methods OA cartilage was obtained from
the patients undergoing total joint replacement. Cartilage
samples from the femoral head at the operation of femoral
neck fracture were used for normal control. DNA fragmen-
tation of chondrocyte was detected by nick end labeling
(TUNEL) method. Apoptosis was confirmed by trans-
mission electron microscopic observation. Expression of
iNOS by chondrocyte was determined by both in situ
hybridization and immunohistochemistry. As a marker of
NO-induced damage of chondrocytes, the distribution of
nitrotyrosine (NT) was examined immunohistochemically.
The population of apoptotic cell and NT positive cells were
quantified by counting the number of the cells. Statistical
significance of the relationship between histological-
histochemical grade, TUNEL positive and NT positive cells
were analyzed using simple regression and Spearman’s
rank correlation test.
Results The positive reactions for TUNEL method were
observed in superficial proliferating chondrocytes, cluster-
ing chondrocytes in OA cartilage, and hypertrophic
chondrocytes in the chondro-osteophyte. Normal cartilage
showed minimal positive reaction. In situ hybridization
confirmed the iNOS mRNA expression by OA chondrocyte.
Histological OA grade (1–11) showed significant correla-
tions with the population of apoptotic chondrocyte (r=0.66,
P<0.05). The population of NT positive cells did not
Osteoarthritis and Cartilage Vol. 8 No. 2 145correlate with OA grade, whereas showed significant cor-
relation with OA grade in early stage (1–5) (r=0.92,
P<0.05).
Discussion Cytotoxicity as a result of long-lasting NO can
cause chondrocyte DNA strand breaks, lipid and protein
modification, and induce chondrocyte apoptosis. In vitro,
NO influences collagen and proteoglycan synthesis by
chondrocyte, interferes chondrocyte migration and attach-
ment to fibronectin, and promotes chondrocyte apoptosis.
Our data strongly suggest the NO-induced chondrocyte
apoptosis play a key role in the process of joint destruction,
especially during the early phase of OA. Selective inhibition
of iNOS is reported to reduce the progression of experi-
mentally induced OA. Moreover, inhibition of NF-B activity,
which is essential for the transcription of iNOS mRNA, with
antisense NF-B or other NF-B suppressive agents, such
as N-acetyl-L-cysteine might be a new therapeutic strategy
for OA.ICE/CASPASE-1 IN HUMAN OSTEOARTHRITIC
TISSUES: LOCALIZATION AND ROLE IN THE
MATURATION OF IL-1 AND IL-18
J. Martel-Pelletier, N. Saha, F. Moldovan, G. Tardif, J. M.
Cloutier and J. P. Pelletier. Osteoarthritis Research Unit,
Centre Hospitalier de l’Universite´ de Montre´al, Campus
Notre-Dame and Campus Saint-Luc, Montre´al, Que´bec,
Canada
Objectives The involvement of the IL-1 converting
enzyme (ICE) in regulating the active level of IL-1 has not
yet been conclusively identified in human OA tissue. We
studied the expression and production of ICE in human
normal and OA cartilage and synovium, and quantitated the
level of ICE in OA chondrocytes. The relationship between
the topographical distribution of ICE, IL-1 and IL-18, as
well as the apoptosis, was also examined.
Methods The expression and synthesis of ICE were
investigated in human normal and OA cartilage and syno-
vial membrane using in situ hybridization and immunohis-
tochemical methods. We also measured the intracellular
level of ICE for OA chondrocytes with a specific ELISA.
Furthermore, we examined by immunohistochemistry the
topographical relationship between the presence of ICE
and mature IL-1, IL-18 and apoptotic chondrocytes.
Results ICE was expressed and synthesized in both
human synovial membrane and cartilage, with a signifi-
cantly greater number of cells staining positive in OA than
in normal tissue. ICE production was preferentially located
in the superficial and upper intermediate layers of articular
cartilage. In this zone, 33.5±4.1% of OA chondrocytes
expressed ICE mRNA compared to 12.3±7.2% (P<0.02) of
normal cells. Similarly, 29.9±5.2% vs 12.3±3.8% (P<0.04)
cells produced ICE protein. In cartilage, IL-1 and IL-18
stained positive at a topographical location similar to ICE.
There was also positive staining in the extracellular matrix
in the OA lesioned areas. The production of mature active
IL-1 in OA cartilage explants and chondrocytes was com-
pletely blocked by treatment with a specific ICE inhibitor,
which also markedly diminished the number of IL-18 posi-
tive cells. Our data showed that there was no close
relationship between the presence of ICE and apoptotic
chondrocytes in OA cartilage, as determined by the TUNEL
technique.
Conclusions This study shows for the first time the pres-
ence of active ICE in human articular cartilage, with a
markedly increased cellular level in OA tissue. The relation-ship between active IL-1 and ICE suggests that ICE may
promote OA progression by activating this proinflammatory
cytokine.HYALURONAN SYNTHESIS IN CARTILAGE AND
POSSIBILITIES OF THE MODULATION
Mamoru Yoshida*, Naoki Itano, Takahiro Sawai, Katsuyuki
Fujii* and Koji Kimata. Institute for Molecular Science of
Medicine, Aichi Medical University, *Department of
Orthopaedic Surgery, Jikei University School of Medicine
Hyaluronan (HA) is not only one of major components of
cartilage and synovial fluid, but also a functional molecule
essential for the formation and maintenance of cartilage.
The elucidation of HA synthetic mechanisms may be
essential to regulate HA synthesis and thereby develop
new therapy for cartilage diseases. We previously cloned
the gene essential for HA synthesis in mouse and human
(hyaluronan synthase 1, HAS1) and have recently con-
firmed the expression in cartilage. In the present study, we
first asked whether this protein alone has an activity to
synthesize HA or the other associated components are also
required. HAS1 protein was expressed in COS1 cells by
FLAG-tagged expression vector and the membrane frac-
tions were isolated. After the extraction with CHAPS, solu-
bilized proteins were subjected to anti-FLAG affinity column
and the affinity fractions were further separated by SDS–
PAGE under non-reducing condition. A single protein band
corresponding to HAS1 protein showed the HA synthase
activity without any further addition except for substrate
sugar nucleotides. Specific activity of HA synthase in the
membrane fraction was 7.6 pmol of GlcNAc transfer/h/mg
of protein and FLAG-affinity fraction showed about 18-fold
specific activity. Since alternative transfer of GlcNAc and
GlcUA residues are required to synthesize HA, the results
clearly demonstrated that the single enzyme protein
retained both the transferase activities of GlcNAc and
GlcUA, which suggested that regulation of HA synthesis
may be possible by modulating the expression and activity
of this protein. We then identified amino acid motif essential
for both the transferase activities in this protein. Site-
directed mutagenesis induced in the cytoplasmic central
loop domain of this protein revealed that several amino acid
residues conserved among various proteins of a HAS
family resulted in the reduction or complete loss of either
the GlcNAc or GlcUA transferase activity. Taken together,
the results suggest that modulation of the hyaluronan
synthesis may be possible by introducing mutated HAS
protein genes into chondrocytes or by other related
methods.EARLY CHANGES IN COLLAGEN BIOCHEMISTRY OF
KNEE CRUCIATE LIGAMENTS AND SUBCHONDRAL
BONE IN A SPONTANEOUS MODEL OF GUINEA PIG
OSTEOARTHRITIS
H. L. Quasnichka, J. M. Anderson-MacKenzie, M. E.
Billingham and A. J. Bailey
The aim of this study, which forms part of our ongoing
investigations into the role of knee ligament and subchon-
dral bone in the development of osteoarthritis (OA), was to
analyse changes in the collagen biochemistry of knee
cruciate ligament and subchondral bone, in spontaneous
OA of the guinea pig, and to determine how these are
related to progression of the disease.
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ligament results in joint instability, leading to a thickening of
subchondral bone and the subsequent fibrillation of carti-
lage, as is observed during the onset of OA. The progres-
sion of OA was examined histologically and radiologically
in Dunkin–Hartley and Strain 2 guinea pigs. Preliminary
results indicate that the Dunkin–Hartley develop OA at an
earlier age than the Strain 2. The extent of collagen
remodelling in the cruciate ligament was examined in
guinea pigs of 3, 6 and 9 weeks of age; both by collagen
cross-link analysis and by use of gelatin zymography to
assess the activity of a gelatinase essential for the diges-
tion of collagen, matrix-metalloproteinase 2 (MMP-2).
Western blotting for an interstitial collagenase matrix-
metalloproteinase-1 (MMP-1), was also performed. Similar
analysis was carried out on subchondral bone extracts from
the six week old samples. Mechanical strength testing was
performed on the anterior cruciate ligament using an
Instron materials testing machine.
Increased collagen remodelling in the cruciate ligaments
of the Dunkin–Hartley compared to the Strain 2 guinea pigs
was illustrated by increases at all ages in MMP-2 activity,
MMP-1 levels and increased immature collagen cross-
links. The anterior cruciate ligaments of the Dunkin–Hartley
guinea pigs at six weeks of age were found to be signifi-
cantly weaker than the ligaments of age matched Strain 2
guinea pigs. This weakness was concomitant with the
observed differences in collagen remodelling between the
strains. Gelatin zymography of the subchondral bone at six
weeks showed the presence of both gelatinases MMP-2
and MMP-9 indicating that bone collagen remodelling was
also occurring.
In conclusion, our initial results from this ongoing work
demonstrate a biochemical difference in the cruciate liga-
ment of two strains of guinea pig which have differing OA
susceptibilities. Our further work on the molecular basis of
collagen expression and degradation in this system will
facilitate elucidation of the role of ligament and subchondral
bone changes in the aetiopathogenesis of OA.RELEVANCE OF RADIO-ANATOMIC POSITIONING OF
JOINTS FOR DIAGNOSIS AND OUTCOME
ASSESSMENT
C. Buckland-Wright. Division of Anatomy, Kings College
London, U.K.
Introduction Poor control of joint position, with regard to
the degree of flexion and rotation, and poor beam align-
ment during radiography results in imprecise and/or dis-
torted images. This leads to failure in correctly assessing
the extent and dimensions of radiographic features: joint
space width (JSW), osteophytes and subchondral scler-
osis, both within and between patients. Standardization of
the radio-anatomic joint position by aligning the X-ray
beam’s central ray with the JSW, controlling both the joint’s
rotation by using a foot (hand) map and the joint to film
distance, reproducible radiographs are achieved. This is
important not only in diagnosis where correct assessment
of the extent of the different radiographic features contrib-
ute to clinical decisions, but also where JSW is used as the
surrogate for quantifying changes in cartilage thickness in
OA clinical trials.
Methods Published radiographic protocols for hip, knee
and hand were evaluated with respect to the following
criteria which contribute not only to precision in the radio-
anatomic positioning of the joint but also to the reliableassessment of the functional status of the articular cartilage
(i.e. compressibility and material thickness) from the JSW
measurement: (1) was the joint weight bearing (for hand
under muscle tension) and was its site of loading consistent
with normal functional or cyclic loading; (2) was the plane of
assessment—measurement (i) perpendicular to the articu-
lar surfaces and to the central ray of the X-ray beam and
parallel to the film, and (ii) for JSW was it coincident with
the principal region of load transmission (since articular
cartilage status is assessed when the measurement is in
this region).
Results The views that best met these criteria for hip was
the A-P view with the beam directed at the joint, and
Lequesne’s special oblique view; for knee with the joint in
the semi-flexed and schuss (tunnel) positions; and for the
hand the P-A view with fingers held together.
Conclusion Further studies are required to determine the
relative sensitivity of the different methods of positioning hip
and knee joints, with and without the use of fluoroscopy,
and the extent to which the views provide relevant data on
the status of OA at the joint.METHODOLOGICAL SUGGESTIONS FOR IMPROVING
RADIOLOGIC ASSESSMENT IN OSTEOARTHRITIS
P. Ravaud, G. R. Auleley and M. Dougados. Service de
Rhumatologie, Hoˆpital Cochin, Paris, France
Radiologic assessment is widely used as endpoint in clini-
cal trials in OA. Despite numerous studies in this field,
many methodological issues are unsolved and need to be
considered. The key points to consider in order to decrease
the noise and increase the signal-to-noise ratio, which
improves our capacity to detect changes using plain radio-
graphics, will be discussed. As examples, the following
issues will be addressed: choice of patients, choice of
view(s), duration of study, choice of features scored,
chronological or random reading order, reading films in
pairs or as single films, optimum number of readers and
quality assurance.
The different methods that should be used to assess
reproducibility (cross sectional reproducibility and repro-
ducibility of progression) and sensitivity to change will also
be detailed.
In addition, the problem of interpretation of radiological
changes observed will be tackled. The interest of using
reproducibility to determine the smallest detectable radio-
logical progression in individual patients over time will be
debated. This cut off permits to summarize the results of
studies in terms of proportion of patients with probable true
organic change (i.e., with a change greater than the varia-
bility inherent both in repeating the imaging procedure and
in the measurement process itself) and of patients who
remain stable (i.e., with a change possibly explained by the
measurement error alone).RADIOGRAPHIC ASSESSMENT OF OSTEOARTHRITIS
T. Conrozier and E. Vignon. Claude Bernard University,
Lyon, France
Conventional radiography is now routinely used for the
assessment of structural lesions of osteoarthritis (OA).
Imaging of OA lesions given by usual radiographs probably
lacks of accuracy. However, radiographic lesions of OA can
be assessed rather satisfactorily.
The kellgren and Lawrence score, which relies on a
mixture of the importance of joint space narrowing (JSN), is
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However its reproducibility and its sensitivity to change
make of the KL a poor method for the assessment of OA
progression. A more subtle evaluation of OA progression
now relies on a separate scoring of each OA lesions. A 4
grade score is generally used for each OA lesion. More
sensitive scores of 6 grades has been proposed for JSN.
The use of an atlas for grading is recommended. Repro-
ducibility of such a scoring is acceptable. However, repro-
ducibility and sensitivity to change is generally better for
JSN than for osteophyte, bone sclerosis and bone cysts.
Assessment of JSN progression is improved by the
measurement of joint space width (JSW). Measurements
are made on radiographs or on digitized images, either with
a graduated magnifying lens or with an image analysis
system. Articular bone edge detection is apparently
improved by digitization. It can be entirely automatized or it
can be made visually after an adequate treatment of the
picture. Minimum JSW (interbone distance) is the more
often measured parameter. A a mean JSW can also be
obtained by the computerized measurement of a surface
area of the joint space. The area is either determined
visually or automatically by the computer. The coefficient of
variation of the various methods of measurement is less
than 10%. Reproducibility of measurement is apparently
improved by the computer analysis of digitized image
(CV<5%). Accuracy of measurement is good enough to
detect a significant progression of JSN over one year in
patient with hip or knee OA. Precision of the method makes
significant a decrease of nearly 0.5 mm in JSN. The relative
merits for the assessment of OA progression of the various
parameters (minimum JSW and mean JSW) and of the
various available methods remain to be evaluated.METHODS WORKSHOP 2: HISTOPATHOLOGICAL
ASSESSMENT OF OA
K. P. H. Pritzker1, K. Ostergaard2 and D. M. Salter3.
1University of Toronto, 2University of Copenhagen, 3Univer-
sity of Edinburgh
Histologic-histochemical grading systems of cartilage and
other joint components are commonly used as a ‘gold
standard’ to assess outcomes of osteoarthritis models.
Presently, these methods are being considered as refer-
ence methods to correlate with noninvasive imaging
modalities in osteoarthritis clinical trials.
This workshop will address the current status of the
histologic-histochemical grading systems for osteoarthritis
with reference in particular to their application to preclinical
and clinical trials.
The features and faults of the current system originally
devised by Henry Mankin will be discussed with regard
to intra- and interobserver reproducibilities and validity
indicators such as sensitivity, specificity, and efficiency.
Use of immunohistochemistry to identify changes in
chondrocyte phenotype and alterations in structure and
content of articular cartilage matrix will be reviewed. The
potential of altered expression of candidate cell-associated
and extracellularly expressed molecules such as
integrins and tenascin in assessment of the grade/stage of
osteoarthritis will be discussed.
The problems of devising a more valid histologic-
histochemical grading system will be described with par-
ticular regard to biologic feature definition, feature selection
and testing the new systems using preclinical model arthri-
tis as well as human normal, and mouse osteoarthritic
study sets.Development of a more valid histologic-histochemical
grading system for osteoarthritis has many benefits. These
include a standard template for assessment of noninvasive
imaging and biochemical markers, and defining better the
sequences of pathologic changes in osteoarthritis. Further,
based on the insights gained by a more valid osteoarthritic
histologic grading system, important new research ques-
tions related to the pathophysiology of osteoarthritis can be
generated.MOLECULAR MARKERS IN
OSTEOARTHRITIS—PROGRESS AND CHALLENGES
L. Stefan Lohmander. Department of Orthopedics,
University Hospital, SE-22185 Lund, Sweden
OA is associated with a loss of the balance between
synthesis and degradation of macromolecules that provide
joint cartilage with its functional properties. The destruction
or remodeling of cartilage and other joint tissues involves
the degradation of matrix molecules, released as fragments
to joint fluid, blood and urine. Such molecular fragments, or
proteases and other molecular factors, can serve as
‘biomarkers’ of joint metabolism in OA. If properly validated,
biomarkers could serve as surrogate measures to deter-
mine prognosis, severity; predict response to therapy,
monitor response to therapy, and to identify disease
mechanisms on the molecular level. Since the markers
reflect dynamic changes, they are perhaps most likely to
serve as surrogate measures of prognosis and response
to treatment. Markers may thus complement existing
measures of OA. They may also uniquely provide
support for proof-of-principle in early-stage trials of new
disease-modifying drugs for OA.
We have shown the increased release of fragments of
aggrecan, COMP, BSP, pro-collagen II C-peptide, and type
II collagen C-terminal crosslinks. Further, the levels are
increased of MMP-1, MMP-3 and TIMP-1 proteins in
human joint fluid after knee injury and in OA. MMP-1
protease activity in joint fluid is increased in OA. MMP
protein levels in synovial fluid are sensitive indicators of
joint pathology. Serum concentrations of MMP-3 increase
after joint injury. The changes are consistent with known
alterations of in vivo and in vitro metabolism in animal
models of OA and joint inflammation, and in vitro in
human OA.
These events point to marked changes in rates of both
matrix degradation and matrix synthesis in OA, and that
markers can reflect such changes. We have determined
between- and within-patient variability for molecular
markers in different body fluid compartments in several
stable cohorts of patients with OA. The availability of such
data now allows calculations to determine the number
of patients needed in prospective studies using
these markers as surrogate outcome measures.
stefan.lohmander@ort.lu.seBIOMARKERS IN OSTEOARTHRITIS (OA) CLINICAL
TRIALS: MONITORING COLLAGEN TYPE II
DEGRADATION PRODUCTS
Ivan G. Otterness1, Thasia G. Woodworth2, Mary J.
Saltarelli3, Kimberly S. Johnson3 and Evelyn H. Pickering4.
1Inflammation, 2Experimental Medicine, 3Clinical
Biochemical Measurements, 4Biometrics, Pfizer Central
Research, Groton, CT, U.S.A.
148 AbstractsBackground Previously, analysis of candidate markers of
joint destruction in blood and urine of OA patients partici-
pating in a NSAID clinical trial showed that these markers
were relatively insensitive and only poorly distinguished
patients from control individuals. Our focus, therefore, has
been the development of novel, clinically relevant biomar-
kers of OA disease status and progression. Because Type
II (TII) collagen gives tensile strength to articular cartilage
and OA is associated with the loss of cartilage tensile
strength, we focused on quantitation of TII collagen break-
down fragments. In theory, elevated levels of TII collagen
breakdown products should be present in the synovial fluid,
blood and urine of OA patients.
Aims of the study To develop an assay to measure
urinary TII collagen fragments and determine whether
the biomarker correlates with OA disease status and
progression.
Methods We prepared two monoclonal antibodies—9A4
to the collagenase-generated C-terminal cleavage
neoepitope (NE) of TII collagen (-Gly-Pro-Pro-Gly-Pro-Gln-
Gly-COOH) and 5109 to a unique TII collagen epitope—to
obtain an assay specific for collagen fragments containing
the TII collagen NE (TIINE). Following assay validation, we
examined longitudinally collected urinary specimens from
over a hundred OA patients with radiographic data at
baseline and 1 year. Standard statistical methodology was
used to determine the performance of the assay and the
correlation with clinical variables.
Results In vitro, collagenase cleaves TII collagen and
slowly releases the neoepitope containing fragments. By
immunohistochemistry, normal cartilage is not strained for
NE by 9A4 while OA cartilage is stained for the NE.
Elevated levels of TII collagen fragments can be found in
the urine of OA patients as compared to controls. We
isolated and sequenced the cleavage products specifically
recognized by the assay and found these fragments to be
of authentic TIINE. Intrapatient variability of TIINE levels
obtained from longitudinal spot urine specimens was
approximately 25%. Elevated TIINE levels were associated
with more severe disease as indicated by radiographic
evidence of joint space narrowing and Kellgren scoring.
Summary Validation of urinary TIINE as a mechanism-
related disease marker is ongoing. Results to date suggest
this marker may have utility in assessing OA severity and in
monitoring OA progression.POSSIBLE APPLICATION OF GENE THERAPY IN OA
C. H. Evans, Ph.D., D.Sc. University of Pittsburgh School of
Medicine, Ferguson Laboratory, 200 Lothrop Street, Room
C-313 PUH Pittsburgh, PA 15213, U.S.A.
Biological therapies offer promising new approaches to the
treatment of OA. For example, there is interest in using
proteinaceous antagonists of interleukin-1 (IL-1) to prevent
matrix breakdown and growth factors to enhance matrix
deposition. Problems associated with delivering such sub-
stances to joints with OA limits their clinical usefulness.
Gene transfer technologies provide possible solutions to
the delivery problem. It is possible to transfer genes to the
synovium and articular cartilage by ex vivo and in vivo
techniques using viral and non-viral vectors. Transfer of
suitable genes to the joints of animals with experimental
models of RA, suppresses disease. There is only one
published report of gene therapy in an experimental model
of OA. This involved transfer of an IL-1Ra gene to the
synovial lining of canine knees after transection of the ACL.The successful development of a gene treatment for OA
requires us to determine which genes to use, where to put
them, how to get them there and how to regulate their
expression.‘THE PROMISE OF BIOLOGICAL AGENTS FOR
OSTEOARTHRITIS THERAPY, CAN IT BE REALIZED’
Larry W. Moreland, M.D. The University of Alabama at
Birmingham, U.S.A.
As the pathogenetic mechanisms of osteoarthritis become
more clearly defined we now have the capabilities of
specifically targeting this disease with agents that either
can inhibit the inflammatory components and/or enhance
the regenerative processes. The therapeutic approaches
that are currently being evaluated in clinical trials including
recombinant insulin growth factor, matrix metalloproteinase
inhibitors, as well as other therapeutic biological response
modifiers will be reviewed. In addition, the potential of other
agents that have been studied in animal models of arthritis
including interleukin-1 receptor antagonists, inhibitors of
tumor necrosis factor, etc., will be reviewed. The potential
of these and other biologic response modifiers hold signifi-
cant promise for patients with osteoarthritis as we are
able to more clearly define the pathways involved in
osteoarthritis.CHEMOKINES AND ARTHRITIS: RANTES IS
EXPRESSED IN CHONDROCYTES AND INDUCES
CARTILAGE DEGRADATION
Nada Alaaeddine, Tsaiwei Olee, Sanshiro Hashimoto and
Martin Lotz. The Scripps Research Institute, La Jolla,
California, U.S.A.
RANTES is a chemokine with the major biologic activity of
chemoattracting various types of leukocytes. Production of
RANTES has been demonstrated in the rheumatoid syn-
ovium and in cultured synovial fibroblasts. However, it
remained to be defined whether RANTES can be produced
by chondrocytes and whether it regulates cartilage metab-
olism. The present study used normal and osteoarthritic
(OA) human cartilage and isolated chondrocytes to exam-
ine RANTES production and function. In unstimulated
chondrocytes the expression of RANTES mRNA was unde-
tectable but increased after stimulation with IL-1 or IL-18.
IL-1 stimulated cartilate also produced RANTES as dem-
onstrated by the immunohistochemical staining and condi-
tioned media from IL-1 treated chondrocytes contained
RANTES protein detectable by ELISA. All OA cartilage
tissues analyzed expressed RANTES mRNA.
Addition of recombinant RANTES to normal chondro-
cytes resulted in mRNA expression of inducible nitric oxide
synthase (iNOS), and IL-6. IL-6 gene expression was
associated with the release of IL-6 protein. Treatment of
normal human articular cartilage with RANTES increased
the release of glycosaminoglycans and hexosaminidase
and profoundly reduced the intensity of safranin O staining.
These findings show that RANTES can be produced by
chondrocytes and identify chondrocyte activation and car-
tilage degradation as novel biologic and pathogenetic
activities of this chemokine.TYPE II COLLAGEN DEGRADATION IS RESTRICTED
TO LESION SITES IN SPONTANEOUS
OSTEOARTHRITIS IN C57BL/6 AND BALB/C MICE
R. Stoop, P. M. Van der Kraan, P. Buma, R. C. Billinghurst*,
A. P. Hollander*, A. R. Poole* and W. B. Van den Berg.
Osteoarthritis and Cartilage Vol. 8 No. 2 149Orthopaedic Research Laboratory/Laboratory for Exper-
imental Rheumatology, University Hospital Nijmegen,
The Netherlands, *Joint Diseases Laboratory, Shriners
Hospitals for Children, McGill University, Montreal, Canada
Degradation of type II collagen is thought to be a key step
in osteoarthritis leading to destruction of the articular carti-
lage. In this study we investigated whether type II collagen
breakdown is confined to the lesion site or can be detected
throughout the tissue. Therefore we studied the localization
of collagen degradation during spontaneous osteoarthritis
in two mouse strains, C57bl/6 and Balb/c mice.
Materials and Methods We used C57bl/6 and Balb/c
mice aged 1–2 years, in which osteoarthritis develops
spontaneously. After sacrifice, both knee joints were dis-
sected, decalcified and 7 m cryosections were made. HE
stained sections were used to detect osteoarthritic
changes. Type II collagen degradation was detected using
imunolocalization directed against the collagenase cleav-
age site in type II collagen (polyclonal antibody Col2-3/
4Cshort). Denatured type II collagen was detected with the
Col2-3/4m monoclonal antibody. This antibody reacts with
a defined epitope in denatured type II collagen.
Results Osteoarthritic changes could be observed in both
C57bl/6 and Balb/c mice. However, a clear difference was
present in the compartmental distribution of the degener-
ative changes. In Balb/c mice, degenerative changes were
mainly located in the patella-femoral compartment, while in
C57bl/6 mice damage was most severe on the lateral side
of the tibia-femoral compartment. In spite of the differences
in location of the OA changes, in both strains staining for
collagen degradation products was restricted directly to the
area where damage of the articular cartilage was seen on
HE-stained sections. Both an upregulation of the colla-
genase cleavage site in type II collagen and of denatured
type II collagen was observed, but the staining of denatured
type II collagen was more intense than the cleavage site
staining. Areas further removed from the lesion sites did not
show collagen degradation. Besides lesion sites, staining
with Col2-3/4m was seen as a pericellular halo around
hypertrophic chondrocytes in the calcified zone of the
articular cartilage. However, no differences could be
observed with respect to this latter staining between knee
joints with or without OA changes.
Discussion Osteoarthritic changes occurred during aging
in C57bl/6 and Balb/b mice, although in different locations.
Notwithstanding the difference in localization, in both
strains type II collagen degradation was restricted to the
lesion sites and could not be found outside damaged areas.
A difficulty of studying collagen degradation by immuno-
localization is that the epitopes are prone to further degra-
dation. However, the observation that staining with both
antibodies is restricted to the lesion site, where catabolism
of collagen most probably is the highest, indicates that it is
unlikely that the lack of staining in non-degraded cartilage
is due to degradation of the epitopes. This study indicates
that collagen degradation during spontaneous osteoarthri-
tis in mice is a very local process, and that a general
breakdown of articular cartilage collagen is not occurring in
the affected knee joints.THE LINKAGE OF MATRIX DEGRADATION AND
CHONDROCYTE APOPTOSIS IN CARTILAGE
S. Hashimoto, R. Ochs, L. Creighton and M. Lotz. Division
of Arthritis Research, The Scripps Research Institute,
La Jolla, California, U.S.A.The occurrence of chondrocyte apoptosis has recently
been linked to cartilage matrix degradation in human and
experimentally induced OA and also in cartilage exposed to
nitric oxide (NO) donors in vitro. The present study exam-
ined whether chondrocyte-derived apoptotic bodies can
degrade matrix in cultured cartilage explants and contain
matrix metalloproteases (MMPs).
Materials and Methods Chondrocyte monolayer cultures
were treated with NO donor sodium nitroprusside (SNP) at
1 mM for 24 h. For isolation of apoptotic bodies the cultures
were harvested (media combined with the residual cell
layer). Cells were removed by a 10,000×g centrifugation
for 20 min and the subcellular particles in the supernatant
from the first centrifugation were pelleted by ultracentrifu-
gation (150,000×g for 1 h at 4°C). Full thickness pieces of
normal human articular cartilage are cultured with or with-
out caspase inhibitor (z-VAD-FMK) and stimulated with
SNP for 48 h. After incubation, culture media were col-
lected to measure proteoglycan release into the media
using DMB assay. Cartilage pieces were incubated with
35S-sulphate for 6 h to measure newly synthesized prote-
oglycan. Cartilage sections were fixed in 10% neutral
buffered formalin for 15 h and embedded in paraffin. In situ
detection of apoptosis was performed using the Apo Tag kit
(Oncor, Gaithersburg, MD). Adjacent sections were stained
with H&E and Safranin O.
Results Western blot analysis showed MMP-1 and 3 to be
present in apoptotic bodies. Chondrocyte derived apoptotic
bodies stimulated proteoglycan breakdown when
co-cultured with cartilage. Caspase inhibitors prevented
SNP-induced chondrocyte apoptosis and also suppressed
proteoglycan breakdown and inhibition of proteoglycan
synthesis in the cartilage.
Conclusions These results suggest that inhibition of
chondrocyte apoptosis could prevent and ameliorate carti-
lage matrix degradation. It may therefore be of therapeutic
value after cartilage injury and in patients with OA.GLUCOSAMINE SULFATE MODULATION OF
AGGRECAN, MMP1, AND MMP3 PRODUCTION BY
CULTURED HUMAN OSTEOARTHRITIS ARTICULAR
CHONDROCYTES
G. R. Dodge, D. F. Hawkins and S. A. Jimenez. Division of
Rheumatology, Thomas Jefferson University, Philadelphia,
PA, U.S.A.
The functional integrity of articular cartilage is largely deter-
mined by the balance between chondrocyte biosynthesis of
extracellular matrix and its degradation. In osteoarthritis
(OA) there is a characteristic increase in matrix degradative
enzymes and a selective decrease in the biosynthesis of
the constitutive extracellular matrix molecules (collagen
types II, IX and XI and the proteoglycan, aggrecan).
Recently, it has been suggested that treatment with gly-
cosamine sulfate (GSO4) may favorably modulate this
balance. Here we used a well-defined suspension culture
of human articular chondrocytes which allows the mainten-
ance of the cartilage-specific phenotype to evaluate the
effects of GSO4 on the biosynthesis of aggrecan and the
production of matrix metalloproteinases MMP-1 and
MMP-3.
Freshly isolated chondrocytes from knee cartilage of OA
patients or normal donors were cultured at a density of
5–10×106 cells/ml in plastic dishes or wells pre-coated with
1.2% of the hydrogel poly (2-hydroxyethyl methacrylate).
The chondrocytes were treated with 0.2–200 M GSO4
150 Abstractsevery 3 days for 14 days. The media were changed at each
3-day interval and the spent media stored frozen with
protease inhibitors. Analyses included Western blots for
aggrecan, MMP-1 and MMP-3, and zymography (casein).
The results showed that treatment of OA chondrocytes
with ≥50 M GSO4 resulted in a dose dependent increase(20–75%) in the expression of the aggrecan core protein as
measured by Western blotting with the monoclonal anti-
body BE123 (kindly provided by T. Glant). A remarkable
finding was the observation that both MMP-1 and MMP-3
were down-regulated in a dose dependent manner (18–
65%) at the earliest time intervals studied. The most
striking results were observed with chondrocytes from a
patient who had not received any anti-rheumatic therapy in
the pre-operative period. The inhibition of MMP-3 detected
in Western blots was paralleled in zymograms. There was
substantial variability in the response of OA chondrocytes
from different patients to GSO4 treatment. It is unclear at
this time whether this variability is related to pre-operative
treatment with a particular agent(s).
Previously, we and others have shown that GSO4 does
not alter the expression of the constitutive collagen type II.
In contrast, the present study indicates that GSO4 can
modify the biosynthesis of aggrecan and, at the same time,
inhibit the production of matrix-degrading metalloprotein-
ases relevant to the OA process. Thus, these studies
suggest that GSO4 may exert beneficial effects in OA due
to its effect on the balance of synthesis and degradation of
extracellular cartilage and to articular cartilage function.CARPROFEN REDUCES THE STRUCTURAL
CHANGES IN EXPERIMENTAL OA: POSSIBLE
BENEFICIAL EFFECT ON SUBCHONDRAL BONE
MORPHOLOGY AND OSTEOBLAST METABOLISM
J. P. Pelletier, D. Lajeunesse, D. Jovanovic, V. Lascau-
Coman, F. C. Jolicoeur, G. Hilal, J. Fernandes and J.
Martel-Pelletier. Osteoarthritis Research Unit, Centre Hos-
pitalier de l’Universite´ de Montre´al, Campus Notre-Dame,
Montre´al, Que´bec, Canada
Objectives This study examined, in the experimental
osteoarthritic (OA) canine model, the in vivo effect of an
NSAID, Carprofen (Pfizer Inc.), on the structural changes.
The effect of the drug on the metabolism of cartilage and
subchondral bone cells was also studied.
Methods A total of four groups (n=26) were included in
this study. Groups I (n=6) and II (n=6) received a section-
ing of the anterior cruciate ligament (ACL) of the right stifle
joint, and were administered Carprofen (2.2 and 4.4 mg/kg/
twice daily/po, respectively) for 8 weeks beginning 4 weeks
post surgery. Group III (n=11) received a sectioning of the
ACL without treatment. All the animals were killed 12 weeks
after surgery. Group IV was composed of unoperated
normal animals (n=3). Cartilage macroscopic lesions were
assessed according to size (mm2), and their histological
severity was graded according to the Mankin scale (grade0–14). For histology, specimens of cartilage and subchon-
dral bones were fixed, decalcified and stained with hema-
toxylin eosin. Levels of metalloprotease (MMP) activity in
cartilage and synovium were measured. Primary cultures of
osteoblasts cells were prepared from the subchondral
bone. The expression of osteoblast biomarkers was also
evaluated, as well as the levels of urokinase plasminogen
activator (uPA) activity and insulin-like growth factor (IGF-1)
in the culture medium.
Results OA dogs treated with Carprofen showed a
decrease in the width of osteophytes (P<0.01), as well as in
the size of cartilage lesions compared with the untreated
OA dogs. The histologic severity of cartilage lesions was
also significantly lower (P<0.008) in the Carprofen groups.
No difference in the levels of MMP activity in the cartilage
and synovium were found when the Carprofen-treated
groups were compared with the OA group. In OA dogs, the
subchondral bone was the site of an extensive remodeling
process favoring bone resorption activity. OA dogs treated
with Carprofen showed a marked decrease in the remod-
eling activity with subchondral bone morphology resem-
bling that of normal dogs. Osteoblasts from untreated OA
animals had a high level of alkaline phosphatase activity
and osteocalcin release compared with normal dogs. In the
Carprofen-treated groups, a marked decrease in these
factor levels was found. uPA activity and IGF-1 levels were
also significantly reduced in Carprofen-treated dogs.
Conclusions This study demonstrated that, under thera-
peutic conditions, in vivo treatment with Carprofen reduced,
in experimental OA, the progression of structural changes
in joint tissues. Data also showed that osteoblasts from OA
dogs have abnormal in vitro behavior, and that Carprofen
treatment can delay and/or prevent the abnormal metab-
olism of subchondral osteoblasts in this model. The hypoth-
esis of a possible link between the protective effect of
Carprofen and its effect on subchondral bone is of a major
interest in the context of future therapeutic intervention.MODERATION OF IODOACETATE-INDUCED
EXPERIMENTAL ARTHRITIS BY MATRIX
METALLOPROTEINASE INHIBITORS
M. J. Janusz, E. B. Hookfin, S. A. Heitmeyer, K. K. Brown,
L. C. Hsieh, N. G. Almstead, B. De, M. G. Natchus, S. Pikul
and Y. O. Taiwo. Proctor & Gamble Pharmaceuticals,
Mason, OH, U.S.A.
Objective To determine the effect of matrix metallopro-
teinase (MMP) inhibitors in mono-iodoacetate induced
arthritis in rats.
Methods The ability of compounds to inhibit MMPs in vitro
was assessed kinetically using a quenched fluorescence
substrate. Rats were injected with iodoacetate intraarticu-
larly in one knee joint and damage to the tibial plateau was
evaluated from digitized images captured using an image
analyzer. Characterization of the joint pathology was also
performed by histology.Table I
Compound IC50 (nM)
MMP-1 MMP-2 MMP-3 MMP-7 MMP-8 MMP-9 MMP-13
PGE-6211443 13±7 3.7±1.1 7.7±2.3 153 ±37 1.4±0.8 2.9±1.4 1.9±1.1
PGE-3162689 4.3±0.7 1.2±0.2 19±2.5 2.1±0.1 0.7±0.2 1.8±0.6 1.4±0.3
PGE-6912923 143±19 <0.4 12±3 3894±665 <0.4 <0.4 <0.4
PGE-9987594 3025±1760 1.4±0.3 21±4.1 4313±709 2.4±0.6 4.1±1.8 1.2±0.4
Data are the mean±SD from 3–5 experiments.
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cacy in the rat iodoacetate arthritis model exhibited various
degrees of selectivity and potency for the MMPs (Table I).
Significant (P<0.05) inhibition of iodoacetate mediated
joint damage was observed in animals treated with 35 mg/
kg b.i.d. of the four different MMP inhibitors. Inhibition of
joint damage by the MMP inhibitors ranged from 36–49%
(Table II).
Conclusion MMP inhibitors are protective against carti-
lage damage and bone remodeling induced by iodoacetate.
These results support an important role for MMPs in
mediating the joint damage in this model of arthritis.WORKSHOP 5: MEASURING OUTCOME IN PATIENT
ORIENTED OA RESEARCH
L. Sharma. Northwestern University, Chicago, U.S.A.
To study the course of a disease in a cohort of patients
requires the application of a template that orders and
organizes complex events sufficiently to allow investigation
and yet is valid. The choice of outcomes and how to
examine them are critical in this template. The goals of this
workshop are to review current recommendations regard-
ing outcome measures and the assessment of disease
progression in patient oriented research in OA and to offer
additional approaches that might be utilized in the future.
At the NIH and AAOS sponsored workshop New Hori-
zons in Osteoarthritis, the following outcomes were empha-
sized: pain, function and radiographic studies. In addition,
recommendations regarding MRI, arthroscopy and biomar-
kers were provided. The OARSI Task Force recommends
assessment of pain, physical function, imaged outcomes,
quality of life/utility, and global assessments. Measures that
are considered optional include: signs of inflammation,
biomarkers, stiffness, performance based measures of
function, presence of flares, time to surgery, and analgesic
consumption.
Though considerable advances have been made in the
assessment of radiographic disease progression and in
the use of patient-centered outcomes, certain outcomes
may deserve greater emphasis given the nature of ques-
tions currently being asked in patient-oriented OA investi-
gation. These outcome categories include patient-centered
functioning (both physical and non-physical), the function/
structure of the joint at an organ level, and biomarkers.
Current evidence suggests that no single outcome
measure adequately summarizes all dimensions of
patient outcome. Approaches taken in recent studies will
be described. While all studies should assess certainoutcomes uniformly to allow between study comparison, it
is beneficial to additionally examine outcomes that are of
particular relevance to the question posed in the study.GLUCOSAMINE SULFATE SIGNIFICANTLY REDUCES
PROGRESSION OF KNEE OSTEOARTHRITIS
OVER 3 YEARS: A LARGE RANDOMIZED,
PLACEBO-CONTROLLED, DOUBLE-BLIND,
PROSPECTIVE TRIAL
J. Y. Reginster1,2,3, R. Deroisy1, I. Paul1,2, R. L. Lee4, G.
Giacovelli5, J. Dacre4, L. C. Rovati5 and C. Gosset1,2.
1Bone and Cartilage Research Unit, University of Liege,
Belgium; 2WHO Collaborating Center for Public Health
Aspects of Osteoarticular Disorders; 3Georgetown Univer-
sity Medical Center, Washington DC, U.S.A.; 4Department
Rheumatology, Whittington Hospital, University College
London, U.K.; 5Rotta Research Laboratory, Monza, Italy
Aim of the study Glucosamine sulfate has been shown in
clinical trials to be a Symptom Modifying Drug in OA.
Although the mechanism of action of the drug is unclear,
pre-clinical studies suggest that it may have also Structure
Modifying properties. This study was designed to test
the effects of glucosamine sulfate on the progression of
knee OA joint structural changes and symptoms, over a
long-term (3 years) treatment.
Methods A prospective, randomized, placebo-controlled
double-blind design was implemented. A total of 212
patients with knee OA (ACR criteria) randomly received
either continuous oral glucosamine sulfate 1500 mg once-
a-day, or identical placebo. Weight-bearing, antero-
posterior radiographs of each knee were taken by a
standardized technique with regard to patient positioning
and radiographic procedure. Mean joint space width (JSW)
of the medial compartment of the tibio-femoral joint was
assessed by digital image analysis by a validated compu-
terized algorithm, with the narrowest medial joint space at
enrolment being taken for the primary evaluation (signal
joint). Symptoms were scored by the WOMAC index, VA3.0
version.
Results The two groups of 106 patients each (78% and
75% women under placebo and glucosamine sulfate,
respectively) were comparable for demographic and
disease characteristics. Mean age was 65 years in both
groups (overall range 51–85 years) and body mass
index was 27 (18–32). Paired radiographs at enrolment
and after 3 years were available for 71 and 68 patients
receiving placebo or glucosamine sulfate, respectively.
There were no differences in any respect between
completers and non-completers, nor the groups differed
for safety or drop-out reasons. Placebo-treated
patients had an average joint space narrowing (JSN) of
approximately 0.1 mm/year, while no JSN occurred in theTable II
Compound Joint lesion score
(mean±SEM)
%Reduction
Vehicle 2.48±0.17 —
PGE-6211443 1.6±0.18* 36
PGE-3162689 1.43±0.1* 42
PGE-6912923 1.47±0.14* 42
PGE-9987594 1.27±0.14* 49
Animals were sacrificed 21 days after receiving iodoacetate.
Joint lesions were scored from 0 (no damage) to 4 (severe
damage). The data are expressed as the mean joint score±SEM
from 15 animals per treatment group.Table I
Placebo Glucosamine
sulfate
JSW enrolment (mm) 5.39 (0.12) 5.23 (0.13)
JSN 3 years (mm) −0.31 (0.13) +0.07 (0.12)*
Total WOMAC enrolment 939.7 (47.1) 1030.2 (46.0)
%variation 3 years +9.8% (12.3) −24.3% (6.4)†
Data are mean (SE). *P=0.038 and †P=0.016 (ANOVA) vs.
placebo.
152 Abstractsglucosamine sulfate group. A slight worsening in symptoms
was evident at the end of treatment with placebo,
compared to an almost 25% improvement after
glucosamine sulfate. Between groups differences were
statistically significant (table).
Conclusions In this large, prospective trial we have
shown potential structure modification by a pharmacologic
intervention. Combined Structure and Symptom Modifying
effects suggest that glucosamine sulfate may be a possible
Disease Modifying agent in OA.TOTAL HIP AND KNEE REPLACEMENT:
PREOPERATIVE FUNCTION AND POSTOPERATIVE
COSTS
Y. St-Pierre1, P. R. Fortin1, J. N. Katz2, J. Penrod1, M.
Tanzer1, M. H. Liang2, N. Mahomed3, C. B. Sledge2 and
A. E. Clarke1. 1McGill University, Montreal, Canada;
2Harvard University, Boston, U.S.A.; 3University of Toronto,
Toronto, Canada
Traditional orthopaedic practice has been to delay surgery
for hip or knee osteoarthritis (OA) until physical function
and pain become intolerable. We have shown that worse
preoperative function and pain predicted significantly worse
postoperative outcome (Fortin et al., Arthritis and Rheuma-
tism, 1999, in press). Utilizing the same patient cohort, we
now test the hypothesis that patients with better preoper-
ative function will incur lower postoperative direct and in-
direct costs (DC, IC), i.e. healthcare costs and productivity
losses.
Patients were recruited at the time they became surgical
candidates for total hip or knee replacement at the Montreal
General Hospital (n=84) and at the Brigham and Women’s
Hospital in Boston (n=138), and were then followed-up for
6 months after surgery. Pain and physical function were
measured using the Western Ontario–McMaster osteoar-
thritis index (WOMAC) relevant subscales and the baseline
function median value was used to dichotomize the cohort
into high/low preoperative function groups. Comorbidities
were assessed using the Cumulative Illness Rating Scale
(CIRS). The economic evaluation was conducted for the
last 3 months of follow-up. Visits to healthcare profession-
als, diagnostic tests, medications and other services,
including ER visits, outpatient surgeries and hospital stays,
were valued using Canadian prices ($CAN97). Diminished
labour market and non-market productivity for patients
and their helpers was valued using Canadian wages.
Unpaid labour was valued in two ways: replacement (RC)
and opportunity costs (OC), assigning domestic wages
to lost hours in RC method and age/gender-specific
wages in OC method. Comparisons were made between
centres and high/low pre-op function groups, and multiple
regression techniques were used to adjust for baseline
status.
At baseline, mean values (SD) for age, education,
WOMAC pain and function scores were respectively 67 (9),
13.3 years (3.7), 10.1 (3.8) and 35.1 (12.9). Median value
for the CIRS was 3 [IQR=(2,4)] and 55.3% of the cohort
was female. Post-surgery, OA patients incurred substantial
healthcare costs over a 3 month period, yielding average
yearly total DC of 4228$CAN. The other services category
represented the largest and most variable cost component
of DC. Productivity losses were on average 40 to 70%
higher than DC, but less than half of patients incurred IC.
For these, average yearly IC was between 12 and
15,000$CAN.Mean cost (SD)
Visits to prof.’s 239 (417)
Diagnostic tests 54 (77)
Medications 170 (122)
Other services 594 (2534)
Total DC 1057 (2.716)
IC (RC) 1474 (2676)
IC (OC) 1783 (3214)
% with IC 45.3%
No significant differences were observed in DC or IC
between centres or high/low pre-op function groups. How-
ever, after adjustment for age, gender, education and
comorbidities, there were significant marginal effects of the
pre-op WOMAC function score, with every additional point
predicting 2% higher DC, as well as 6% higher odds of
incurring IC. Thus waiting for an increase of 10 WOMAC
points before operating results approximately in a 20%
increase in post-op DC, i.e. 850$CAN per year on average,
and a 60% increase in the odds of incurring IC of 12 to
15,000$CAN per year on average.
Longer delay before surgery, as indicated by worse
preoperative functional status, results in higher postopera-
tive costs, both in terms of healthcare utilization and
productivity losses.VALIDATION OF THE WOMAC 3.0 TS, AN
AUDIOVISUAL COMPUTERIZED VERSION OF THE
WOMAC 3.0
R. Theiler*, S. Kroesen*, J. Spielberger* and N. Bellamy†.
*Rheumatology Unit, Kantonsspital Aarau, Switzerland and
†Rehabilitation Unit, University of Queensland, Australia
Introduction The condition specific health outcome
measure instrument WOMAC (Western Ontario McMaster
University Questionnaire) is widely used to get information
about pain and disability of patients suffering from osteoar-
thritis (OA) of the lower limb (hip/knee OA). This question-
naire consists of three different sections, namely pain,
stiffness and function. A German version was validated
earlier.1
A computer-assisted touchscreen (TS) application of the
WOMAC 3.0 was developed.
Aims The objective of this study was to validate the
computer assisted application of the WOMAC 3.0.
Methods Fifty patients with OA of the lower limb filled out
the paper version of the WOMAC questionnaire. Ten min-
utes later the computerized version was administered to
the same patients, supposing that the patient was not able
to remember the accurate answer of the first self adminis-
tered questionnaire. The computerized version is an audio-
visual touch-screen (TS) version of the WOMAC 3.0. The
patient is guided through the questionnaire by the program.
The questions were answered by marking a monochro-
matic analog-scale with scores from 0 to 10. The questions
were answered by touching the screen.
Statistically the mean of the score-difference between
each question was calculated. By using the standard error
the 95% confidence interval was calculated. Further on
the paired, two tailed student’s t-test was performed to
compare the two versions of the questionnaire.
Results There was no significant difference between the
two versions. The computerized WOMAC was well
accepted by the patients, even by very elderly people. By
finishing the questionnaire no missing data occurred,
Osteoarthritis and Cartilage Vol. 8 No. 2 153because the next question could only be answered after
answering the question before.
Conclusion An audiovisual touch screen format of the
WOMAC 3.0 was developed and seems to be a useful tool
in daily practice as well as in electronic data capturing
processes such as in clinical OA trials.Reference
1. Evaluation of German version of WOMAC (Western
Ontario and McMaster Universities) Arthrosis Index.
Z Rheumatol 1996;55(1):40–9.THE RELATIONSHIP OF BONE DENSITY TO THE
SUBSEQUENT INCIDENCE AND PROGRESSION OF
RADIOGRAPHIC OSTEOARTHRITIS OF THE KNEE:
THE CHINGFORD STUDY
D. J. Hart1, D. V. Doyle2 and T. D. Spector1. 1Twin
Research & Genetic Epidemiology Unit and 2Department of
Rheumatology, Whipps Cross Hospital, London, U.K.
Previous cross-sectional studies which are subject to
selection biases have reported small increases in bone
mineral density (BMD) in subjects with osteoarthritis (OA),
thus supporting the hypothesis that decreased bone mass
and OA rarely co-exist. Therefore we followed up 830
middle-aged women from the Chingford population to
examine the association with incident and progressive OA.
Eight hundred and thirty women had repeat AP weight-
bearing knee radiographs 48 months after baseline knee
radiographs. All radiographs were graded blinded to time
sequence by one observer using individual features of
osteophytes and joint space narrowing with a 0–3 scale of
severity using a standard atlas of radiographs. Incident
knee OA was defined as new disease in the 715 women
free from knee OA at baseline. Progression was defined as
change in at least 1 grade from 115 with baseline knee OA.
All women had baseline bone densitometry of the lumbar
spine and hip. Mean bone density and percentage differ-
ence was calculated between cases and non-cases at each
site. All results were adjusted for potential confounders.
Ninety-five women with incident knee osteophytes had
significantly higher lumbar spine BMD (+6.3% P=0.002)
than normals (1.01 g/cm2 vs 0.95 g/cm2), and significantly
higher hip BMD (+3.9% P=0.02) than those without inci-
dent disease (0.79 g/cm2 vs 0.76 g/cm2). For the 33
women whose osteophytes progressed no difference was
seen compared to non-progressors in spine BMD, but hip
BMD was modestly reduced (−2.5% P=0.36).
Eighty-one women who had incident joint space narrow-
ing had higher spine BMD (+3%) although this was non-
significant. No difference was seen for the 30 women
whose narrowing had progressed. For the hip no difference
was seen for incident narrowing and again a non-significantreduction in bone density was seen in those whose
narrowing progressed (−2.7%).
In summary, these results confirm that spine and hip
BMD is higher in women who later develop incident knee
osteophytes to the same magnitude as shown in cross-
sectional studies. Low BMD at the hip appears weakly
related to OA progression. These results suggest a com-
mon role of bone turnover in the aetiopathogenesis of OA.SERUM CARTILAGE OLIGOMERIC MATRIX PROTEIN
LEVELS INCREASE WITH KNEE PAIN IN BOTH THE
PRESENCE AND ABSENCE OF RADIOGRAPHIC
OSTEOARTHRITIS
A. G. Clark1, J. M. Jordan2, A. D. Dragomir2, G. Luta2, J. B.
Renner2, V. Vilim3 and V. B. Kraus1. 1Departments of
Pathology and Medicine, Duke University, Durham, NC,
U.S.A.; 2University of North Carolina at Chapel Hill, Chapel
Hill, NC, U.S.A.; 3Institute of Rheumatology, Prague, CZ
Aim To evaluate the relationship between serum COMP
levels and knee joint pain in both the presence and
absence of osteoarthritis (OA).
Methods Samples were obtained as part of the Johnston
County Osteoarthritis Project, a population-based study of
OA in rural North Carolina. Weight-bearing anteroposterior
radiographs of the knees and hips, as well as serum, were
collected without regard to prior knee pain or OA status. Of
866 eligible Caucasian study participants, 143 osteoarthri-
tis cases (radiographic knee OA Kellgren–Lawrence grade
≥2) and 148 controls (Kellgren–Lawrence grade 0 knee and
hip radiographs) were randomly selected for this study.
Cases and controls were further divided into groups based
on the self-reported presence or absence of knee pain,
aching, or stiffness on most days. Serum COMP was
analyzed blindly and in duplicate by inhibition enzyme
linked immunosorbent assay (ELISA) with monoclonal anti-
body 17-C10. The data were ln transformed to satisfy the
assumptions of general linear models. Pairwise compari-
sons between subgroups were analyzed by ANOVA
methods. The test for linear trend was performed to assess
the linear relationship between means for ln transformed
serum COMP levels and the OA and/or knee pain variable.
Results For the non-OA group, serum COMP was
increased in those with knee pain (n=48) compared to
those without knee pain (n=96; mean±std.dev.=
1124.89±428.03 ng/ml vs 1031.91±339.62 ng/ml respect-
ively). A similar increase in serum COMP with knee
pain was seen in the OA affected group; mean±
std.dev.=1230.01±522.91 ng/ml for those with knee pain
(n=77) and 1183.55±445.23 ng/ml for those with no knee
pain (n=66). Although pairwise comparisons between indi-
vidual groups were not statistically significant, possibly due
to relatively small sample sizes, the test for linear trend
showed high significance (P=0.0050), indicating a strongTable I
Mean spine and hip BMD (g/cm2) and SD with % difference for knee osteophytes
Spine BMD Hip BMD
N Incidence N Progression Incidence Progression
620 0.95 (0.15) 82 0.99 (0.15) 0.76 (0.12) 0.79 (0.12)
95 1.01 (0.17) 33 0.99 (0.17) 0.79 (0.12) 0.77 (0.12)
P=0.002 P=0.90 P=0.02 P=0.36
+6.3% 0% +3.9% −2.5%
154 Abstractslinear relationship between serum COMP and the OA
and/or pain variable. This trend remained significant even
after adjustment for age, gender, and obesity (P=0.0157).
Conclusions A recent population-based study of osteoar-
thritis, depression, and knee pain found that women with
knee pain but no OA had significantly higher levels of
depression than those with both knee pain and radio-
graphic OA.1 The results implied that knee pain among
women with no OA was a manifestation of depression
rather than joint disease. However, our results suggest that
pain, even in absence of radiographic disease, may also
reflect degradative or inflammatory changes occurring in
the joint. We have shown that serum COMP increases with
OA, number of knee and hip joints affected by OA, and
severity of disease.2 Serum COMP has also been shown to
increase with synovitis.3 Further studies will be needed
to determine the relative degree to which subacute
cartilage degeneration, inflammation, or depression may
contribute to knee pain as experienced in individuals with
no radiographic disease.References
1. Brandt KD et al. Trans Orthop Res Soc 1999;45:222.
2. Clark AG et al. Trans Orthop Res Soc 1999;45:221.
3. Vilim V et al. Trans Orthop Res Soc 1999;45:441.HISTOLOGICAL AND MOLECULAR CHANGES IN
OVER-EXERCISED KNEE JOINTS OF
INTRACRANIALLY SELF-STIMULATED (ICSS) WISTAR
RATS RESEMBLE THOSE IN HUMAN
OSTEOARTHRITIS (OA): IMPLICATIONS FOR THE
USE OF THIS NOVEL ANIMAL MODEL
T. Pap, G. Pap*, A. Machner*, Y. Shigeyama, T. Rinnert*, H.
Schwarzberg**, R. E. Gay, W. Neumann* and S. Gay. WHO
Collaborating Center for Molecular Biology and Novel
Therapeutic Strategies for Rheumatic Diseases, Depart-
ment of Rheumatology, University Hospital, Zu¨rich,
Switzerland; *Clinic for Orthopedic Surgery and **Institute
of Physiology, University Hospital, Magdeburg, Germany
There is significant evidence that the mechanical stress
contributes to the development of OA. In this context, a
novel animal model of OA has been developed, in which
intracranial self-stimulation (ICSS) of Wistar rats in a run-
ning wheel leads to the development of an exercise depen-
dent OA. Here, we sought to characterize this model by
studying the morphology of the changes as well as inves-
tigating alterations in the expression of MMPs and the
apoptosis regulating Bcl-2 in comparison to human OA.
As seen before, excessive running resulted in the devel-
opment of a moderate OA in the knee joints of the animals.
Apart from being clearly exercise-dependent, osteoarthritic
damage was significantly more severe in the medial com-
partments both on a histological and molecular level as
assessed by evaluating the immunoreactivity against
MMP-3 and MMP-13. In addition, histological evaluation
revealed the presence of early stages of osteophyte forma-
tion in those animals with the highest running load. These
changes were accompanied by a marked expression of the
anti-apoptotic molecule Bcl-2 in both chondrocytes and
fibroblasts. In the chondrocytes, expression of Bcl-2 was
most intense at sites of beginning osteophyte formation.
However, several Bcl-2 positive chondrocytes were also
found in the superficial layer of the cartilage, particularly atsites of destruction. Studies in tissue samples of human OA
demonstrated a similar pattern of Bcl-2 expression. Using
quantitative, real-time PCR (TaqMan® system, Perkin
Elmer), a 15-fold increase in the expression of bcl-2 mRNA
could be found in human OA synovial fibroblasts as com-
pared to normal fibroblasts. Interestingly, bcl-2 expression
levels in OA fibroblasts also exceeded those in rheumatoid
arthritis fibroblasts and fibroblasts from the interface
membrane around loose joint prostheses.
We conclude from these data that the histological and
molecular changes seen in the ICSS Wistar rat model of
OA resemble important aspects of human OA. Therefore,
this model appears to constitute a novel tool for studying
the pathogenesis of cartilage erosions in OA. In addition,
the data suggest that expression of Bcl-2 may be related to
certain stages of OA, not only in the response to cartilage
damage, but also in the formation of osteophytes.OUTCOME MEASUREMENTS IN THE SURGICAL
TREATMENT OF OSTEOARTHRITIS
Go¨ran Garellick MD, PhD
‘Despite more than fifty years experience with outcome
measurement in musculoskeletal clinical trials, there
remains a diversity of opinion and a lack of adequate
standardization in the methods employed . . .’ (Bellamy,
1993). The above quotation is embarrassing but unfortu-
nately still a reality. The present review concerns clinical
outcome measurements after total hip replacement (THR)
surgery but is applicable in all fields of surgical treatment of
osteoarthritis.
Approximately 20 different hip scores have been pre-
sented in the literature. The majority of these disease
specific scores were published before 1970. Commonly
measured variables are: pain, walking distance, limp, range
of movement, and so forth. Patient satisfaction is seldom
included. Most of the scores sum the obtained values to a
total score. These numerically based instruments have
provided a basis for comparison of results of follow-up
studies of THR. Because these scoring systems are easy
and convenient to use, they are widespread throughout the
orthopaedic community and have been the standard for
clinical assessment over the last four decades.
There has been a great number of critical studies ana-
lyzing and comparing commonly used hip scoring instru-
ments. Many of these studies have concluded that the
different hip scores often give contrary measures of suc-
cess in the same patient and that they lack any kind of
validation. Inhomogeneous patient material (case mix) is a
major reason for the inconsistency in results reported when
traditional score systems have been used. It is not mean-
ingful to compare the outcome scores between patient
groups with highly variable age or different diagnoses. Hip
scores may decline over the course of a long-term
follow-up period due to factors not related to the THR.
With increasing concern regarding the rising cost of
health care, there has been a growing interest in outcome
studies. Not only the orthopaedic community has an inter-
est in assessing outcome after THR surgery, but also
epidemiologists, health care producers, economists and
politicians have shown an increasing interest in the out-
come evaluation of this widespread and cost consuming
operation. An international consensus, that outcome instru-
ments should fulfil some basic criteria for scientific pur-
poses, is now obtained. All measurement tools should be
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score is used internationally for comparing different studies,
translation is an important issue. After translation the score
must be tested for the basic criteria in the current language.
With the intense focus on costs and limited resources, it
is necessary to identify which medical intervention is effec-
tive and significantly improve the condition of treated
patients. Therefore, there has been an increasing interest
for incorporating ‘Quality of Life’ (QoL) in the evaluation of
medical treatments. The advantage of QoL or a generic
measure compared to a disease-specific measure is the
ability to compare outcomes across different populations
and medical interventions, particularly for cost-
effectiveness studies, policy analysis, and decision making.
A number of instruments for measuring subjective QoL in
clinical trials are now available. No single general measure
is likely to meet all the needs of investigators and specific
populations. Patients with different medical conditions
require different emphasis on generic concepts of health.
Although standardization is a marked advantage with
generic measures, the length and complexity of some
measures are disadvantageous. Extensive questionnaires
are laborious and can jeopardize the compliance of incom-
ing patients.
The statistical methods used in survival analysis have
been developed in the last four decades, principally for
cancer research. Only under the last decade have they
been adapted for use in orthopaedic surgery, presumably
for evaluation of the longevity of implants. The definition of
endpoint failure in a survival analysis is of critical impor-
tance. The survival technique has some drawbacks and
must be interpreted cautiously. The weaknesses of the
technique have to be taken into consideration; if not there is
an obvious risk that the presented results may be mislead-
ing or artificially optimistic.
Problem One study is often compared with outcome from
another and the difference measured. In a strict scientific
way, such a comparison is only possible if the entry criteria
and measurement tools are equal and scientifically valid
among the different studies. This is not the reality in the
orthopaedic literature today, despite the fact that several
editorials have addressed this problem. Previous attempts
by various committees, such as SICOT, AAOS and The Hip
Society, to standardize definitions and promote generally
accepted terminology have failed.
Future recommendation The most important issue is,
however, not how we measure outcome but that we reach
an international consensus on standardization of outcome
measure, making comparison between different studies or
implants possible and meaningful.MEDIAL MENISCUS CHANGES WITH XP GRADE
PROGRESSION IN THE EARLY OSTEOARTHRITIC
KNEE STUDIED BY MRI RADIAL IMAGES
Y. Matsui, Y. Oishi, Y. Hirano and M. Shin. Toyohashi
Municipal Hospital, Toyohashi, Aichi, Japan
Changes in the medial meniscus (MM) in the early osteoar-
thritic (OA) knee were compared among each part of MM
and also depending on the Xp grade so as to investigate
the pathology or cause of pain in the early OA knee, which
has not yet sufficiently elucidated.
Methods MRI radial sections of 70 early OA knees of 68
middle aged or elderly subjects (22 men, 46 women) were
studied. Average age was 57.7 years old (45–79 years old).Those knees with no joint space left in Xp were not
included. Siemens Magneton 1.5T was used with FISP
(Fast Imaging with Steady Precision) 3D+MPR (Multi
Planar Reconstruction) technique to obtain 9 reconstructed
sections of MM at 20 degrees of rotation. Four of 9 sections
(anterior, mid-anterior, mid-posterior and posterior) were
evaluated for the following items. (A) Degeneration of
substance, (B) width, (C) peripherally extruded length from
the edge of the tibial plateau, (C/B) proportion of peripheral
extrusion, (D) peripheral edge loosening and (E) angle
between the upper and lower edges. (A) and (D) were
evaluated in 4 grades of 0, 1, 2 and 3. Cases were
classified into three groups according to Xp grades, O, I, II
(O indicates no joint space narrowing, 1 narrowing less
than half, and II more than half). The comparisons were
made among groups to investigate changes in MM with Xp
grade progression.
Results When the grade of Xp progresses, degeneration
of the substance increased (especially between grade I and
II at every part), peripheral extrusion increased (more than
45% in the anterior and mid-anterior of grade II) and angle
between the upper and lower edges also increased
(especially between grade O and I of mid-anterior
and mid-posterior). Width was narrowest in grade I, but
peripheral edge loosening did not differ among groups.
Discussion Using FISP 3D+MPR technique, which can
reconstruct any sectional image, this study demonstrated
that peripheral edge extrusion of MM (especially in anterior)
from the tibial plateau tends to increase, together with
increased degeneration (especially in posterior) as Xp
grade progresses. Anterior malposition of MM as well as
advanced degeneration in posterior may hinder smooth
meniscal excursion during flexion-extension or rotational
knee motion. This may be one of the main causes of medial
pain which is commonly seen from the early stage in the
OA knee especially at the time of start of motion.CARTILAGE LOSS IN PATIENTS WITH SEVERE
GONARTHROSIS—QUANTIFICATION WITH A RAPID
3D FLASH WATER EXCITATION SEQUENCE
C. Glaser, F. Eckstein, R. Burgkart, S. Faber, K-H.
Englmeier and M. Reiser. Institute of Diagnostic Radiology,
LMU Munich, Germany
Aim Validation of a 3D Flash Water Excitation (WE)
sequence with reduced acquisition time for cartilage vol-
ume and thickness measurements. Assessment of tibial
cartilage volume and thickness in patients with severe
gonarthrosis in comparison to healthy volunteers.
Material and Methods Validation: Two sagittal datasets
(resolution 0.31×0.31×2 mm3) of the knees of 9 healthy
volunteers were acquired with the 3D Flash WE sequence
(17.2/6.6/30°, acquisition time 7′14″) and with a previously
validated 3D Flash sequence with spectral fat suppression
(FS) (45/11/30°, acquisition time 16′30″). After semiauto-
matic segmentation and 3D reconstruction, cartilage vol-
ume, mean, and max. cartilage thickness were determined
by a 3D Euclidean distance transformation for the patellar,
femoral, med. and lat. tibial compartment. Patients: Four
consecutive coronal datasets of the knees of another 6
healthy volunteers and of 6 patients with severe gonarthro-
sis undergoing knee arthroplasty were acquired (resolution
0.31×0.31×1.2 mm3) with the WE sequence. The knees
were repositioned between the acquisitions. Cartilage vol-
ume and thickness were determined as explained above.
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ation (COV) for patients and volunteers. All images were
acquired in a 1.5 T scanner with a CP extremity coil.
Statistical analysis was performed using the Wilcoxon test.
Results In all knee compartments the values for cartilage
volume and thickness in both sequences agreed with 4%
from each other. There was no statistically significant
difference between WE and FS sequence. Within the
patient group cartilage volume and mean cartilage thick-
ness were significantly smaller (vol.: 923±318 vs
1447±422 mm3) in the more heavily affected compartment
(P<0.01). There was cartilage volume loss of up to 58%/
43% in the med./lat. tibial plateau compared to the volun-
teers. Reproducibility (COV) in the patient group was 5.9%
(med.) and 3.2% (lat.) tibia.
Conclusions The use of a rapid 3D Flash WE sequence
with reduction of acquisition time down to 6–7 min enables
routine clinical use of this sequence. The sequence is valid
for quantitative assessment of articular cartilage volume
and thickness and provides good reproducibility in patients.
Cartilage loss in severe gonarthrosis can be directly quan-
tified in vivo by MRI establishing a basis for follow up of
degenerative joint disease before and after therapy and for
assessing therapeutic efficacy at long term.NEW TECHNIQUE AND REPRODUCIBILITY OF THE
MANUAL MEASUREMENT OF THE OSTEOARTHRITIC
(OA) HIP JOINT SPACE (JS)
M. Lequesne, C. Cadet and G. R. Auleley. L. Bellan
Hospital, Paris, France
Measurement (meas.) of the course of the joint space
narrowing (JSN) over 2 to 3 years on plain radiograph is
usually selected as the primary criterion in trials of possible
structuromodifying drugs for OA of the hip and knee.
Aim To evaluate the possible improvement in the latest
technique of meas. in comparison with previous ones.
Methods Thirteen pairs of pelvis X-rays in standing posi-
tion taken 2 years apart, i.e. 26 radiographs of OA hips
were selected as representing various degrees of JSN.
They were mixed up and numbered (random list). Meas. of
the JSN at its narrowest point was performed 4 times
(blindly, one month apart) by one of us with the help of 3 (B,
C, D) different techniques (Tech), i.e. 312 meas. A 0.1 mm
graduated magnifying glass was used. In tech B, it was
applied directly on the radiograph. Tech C: a small and
short stroke of pencil was applied on the subchondral bone
contour at the JSN relevant site; Tech D: the pencil was a
special one, ‘paper glass’, able to mark clearly a fine stroke;
this stroke was placed more precisely with the help of a
common lens (diameter 9 cm); the reader was seated; the
viewing box was horizontal. Two readers (ML and CC) were
evaluated separately using blindly this tech D. Statistical
analysis involved means and SD for every session, intraob-
server coefficient of variation (CV), intraclass correlation
(ICC) and graphical method of Bland and Altman.
Results Various values of JSN: 0.3 to 4.2 mm. Half (n: 13)
≤2.5 mm. Intra observer reproducibility (3 tech, 2 readers
for tech D)
techB techC techD D, 2nd reader
CV 15.3% 8% 5.7% 3.6%
ICC 0.88 0.97 0.98 0.99
Bland and Altman: the limits of agreement were +0.21 and
−0.26 for the 1st reader and +0.22 and −0.23 for the 2nd
reader, both with tech D (Fig. below).Conclusion Several new developments in the technique
of the manual measurement of OA JS width have resulted
in the improvement of the reproducibility of the method: CV
5.7% instead of 8–15% in the past. However, readers are
not equally precise: CV 1st: 5.7%; CV 2nd: 3.6%, with the
same technique. Several readers have to be tested to
select the best performing one.FUNCTIONAL RESPONSE OF ARTICULAR
CARTILAGE TO PHYSICAL LOADING IN
VIVO—ANALYSIS WITH MAGNETIC RESONANCE
IMAGING
M. Tie`schky#, B. Lemberger#, S. Faber*, C. Glaser*, K.-H.
Englmeier°, M. Reiser* and F. Eckstein#. #Musculoskeletal
Research Group of the Anatomische Anstalt, Munich,
Germany; *Institut fu¨r Radiologische Forschung, Klinikum
der LMU, Munich, Germany; °MEDIS Institut der GSF,
Neuherberg, Germany
Although changes of mechanical properties of articular
cartilage play a major role in joint diseases, compression
experiments so far have concentrated on explanted tissue
samples, and there has been almost no information about
the deformational behavior of articular cartilage under load-
ing conditions in the living. Surprisingly, there exist no data
on the magnitude of cartilage deformation occurring in
intact joints during normal loading. The aim of this
study was, therefore, to examine the extent and pattern
of patellar cartilage deformation during and after static
and dynamic loading in vivo, including the degree of
deformation, recovery time, and fluid flow.
The right patellae of 7 healthy volunteers were imaged at
rest and after multiple sets of 50 and 100 deep knee bends,
respectively, with a fat-suppressed FLASH-3D sequence.
Another 12 healthy volunteers were imaged with a water
excitation gradient echo sequence before and after static
exercise (squatting at 90° knee angle) and dynamic exer-
cise (30 deep knee bends), both sequences having been
validated previously. The volume and thickness changes of
the patellar articular cartilage were determined in every
case after 3D reconstruction on a multiprocessing graphics
workstation and digital image analysis.
After 50 deep knee bends, the cartilage volume changes
ranged from 2.4% to 8.6% (mean=5.8%), and from 2.4% to
8.5% (mean=6.0%) after 100 knee bends, respectively.
Repeated sets of dynamic exercise at 15 min intervals did
not cause further deformation. The recovery time for the
cartilage after 100 knee bends was more than 90 min. The
fluid flow rate at recovery ranged from 1.1 to 3.5 mm3/min
(mean=2.4 mm3/min, corresponding to 0.08 to 0.22 mm3/
min per cm2 of articular cartilage surface). The rate of fluid
flow was highly correlated with the individual degree of
cartilage deformation after knee bends (r>0.9). After 30
knee bends there also was a significant reduction of the
cartilage volume (mean=5.9%±2.1%), and a reduction of
the maximal cartilage thickness (mean=2.8%±2.6%). The
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and medial patellar facet. After squatting, the cartilage
volume reduction was significantly less than after dynamic
exercise (mean=4.7%±1.6%), but the reduction of the
maximal cartilage thickness was significantly higher
(4.9%±1.4%). Here, the maximal cartilage deformation
was recorded in the inferior lateral patellar facet. The
correlation of deformation after static and dynamic loading
was 0.69.
These data provide the first in vivo quantification of
articular cartilage volume and thickness changes during
loading, and of the recovery time and rate of fluid flow
between the cartilage matrix and the surrounding tissue in
intact joints. They suggest a high interindividual variation of
mechanical cartilage properties. There are different effects
of static and dynamic loading on articular cartilage. The
observations may serve as a basis for relating cartilage
properties to the susceptibility of developing joint failure, for
determining the role of mechanically induced fluid flow in
the regulation of metabolic activity of chondrocytes, and for
estimating the strain of transplanted cartilage during normal
joint use.ARTICULAR CARTILAGE WEAKENING PRECEDES
FIBRILLATION
D. J. Adams2, I. G. Otterness3 and J. L. Lewis1. 1University
of Minnesota, Minneapolis, MN, U.S.A.; 2University of
Connecticut Health Center, Farmington, CT, U.S.A.;
3Pfizer Inc., Groton, CT, U.S.A.
Introduction Osteoarthritis involves fibrillation and mech-
anical breakdown of the articular cartilage surface.
Although there is indirect evidence that cartilage weakens
with the development of OA, there has been no direct
support of the hypothesis that weakening precedes fibril-
lation and cracking of the articular surface. The hypothesis
was tested by adapting a microscratch mechanical test
method to assess the fracture strength (toughness) of
articular cartilage in hamsters following intra-articular injec-
tion of lipopolysaccharide (LPS). LPS causes negligible
fibrillation at 4 or 21 days after treatment; however, if the
cartilage is stressed by daily ad libitum running extensive
fibrillation develops after 21 days (Shay et al., Rheum Int,
14:183–9, 1995).
Methods Female Syrian hamsters approximately 73 days
of age were allowed to run ad libitum on a wheel for 10
days. On day 6, the knee joints of the treatment group were
injected with 1 g of LPS. Animals were killed on day 10
and the legs stored at −80°C. To assess the mechanical
integrity of the cartilage, femurs were dissected of all soft
tissues and fixed to the bottom of a glass cup to position the
posterior surface of the condyles for testing. The cup was
filled with saline, mounted within the stage of a custom
nanoindentation test system, and allowed to equilibrate.
Using a conical diamond tip (90° cone, 1 m tip radius),
scratches were made along the curved articular surface in
a sagittal plane while measuring forces on the tip. Fracture
tests were conducted by penetrating the sharp diamond tip
into the cartilage surface to a depth of 30 m, and then
moving the tip laterally while maintaining the penetration
depth. Forces were measured in the vertical and horizontal
directions while ‘scratching’ the curved surface 600 m at
2 m/sec. Fracture toughness was calculated as the rate of
scratch work divided by the rate of surface area generation.
At least 6 tests were performed on the medial
femoral condyle of each animal. The articular surfacesand resulting fracture patterns were examined with SEM
imaging.
Results Fracture toughness for control animals was
153±30 Nm/m2 (n=4), and 53±10 Nm/m2 in the LPS-
injected animals (n=4). The difference between groups was
statistically significant at P=0.0007 (unpaired, two-tailed
t-test). SEM imaging showed fracture patterns following
the linear scratch paths. There was no evidence of
fibrillation.
Conclusions The fracture toughness of cartilage from the
injected joints was one-third the value of the non-injected
controls. Since there was no fibrillation at 4 days after
injection of LPS, but fibrillation does appear at 21 days in
running animals, we conclude that cartilage weakening
precedes fibrillation in this model. Measures of fracture
touchness produced by the microscratch technique dem-
onstrated a weakness in cartilage that had not manifested
as fibrillation, and may be a useful outcome measure for
OA animal models.REGULATION OF THE CYCLOXYGENESE-2
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The expression of the cyclooxygenase-2 (COX-2) gene is
stimulated by interleukin-1 (IL-1) in articular chondro-
cytes. The promoter region of COX-2 harbors regulatory
elements for CRE-C/EBP (−59; −53 bp), C/EBP (−134;
−126 bp) and NF-B (−441; −451 bp and −226; −217 bp).
The aim of this study was to determine the transcription
factors involved in IL-1-mediated stimulation of the COX-2
promoter. Rabbit articular chondrocytes in primary culture
were treated with IL-1 10 ng/ml for 1–24 h. Analysis of the
functional activity of the COX-2 promoter was studied using
different CAT reporter constructs of the COX-2 promoter
containing 5′ deletions and site-specific mutations trans-
fected in control and IL-1-stimulated chondrocytes. IL-1
increased promoter activity by .3 fold. The proximal, but
not the distal, NF-B site regulated IL-1 induction of the
COX-2 promoter. Kinetics of electrophoretic mobility shift
assays (EMSA) with the proximal NF-B site revealed
maximal binding of NF-B 2 h after IL-1 stimulation that
was still present at 24 h. An unidentified factor was consti-
tutively bound to the proximal NF-B site. Mutation of the
proximal C/EBP site inhibited IL-1-mediated stimulation.
EMSA revealed binding to the COX-2 C/EBP sites. Amid
the C/EBP factors, C/EBP and C/EBP, but not C/EBP,
are critical for the IL-1-mediated stimulation. IL-1
increased the mRNA level of C/EBP in chondrocytes, but
regulated C/EBP at a different level.
Taken together, our data demonstrate that C/EBP and
NF-B factors function in concert to augment COX-2
promoter after IL-1 stimulation in chondrocytes.BONE MORPHOGENETIC PROTEINS: PROTECTIVE
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T. Ha¨upl, U. Ungethu¨m, C. Bramlage, C. Kaps, G. Keyßer,
K. Labs§, J. Zacher†, M. Sparmann*, M. Sittinger, G.
Gross# and G.-R. Burmester. Department of Rheumatol-
ogy, §Department of Orthopedics, Charite´, Humboldt-
University Berlin, *Department of Orthopedics, Immanuel
158 AbstractsKrankenhaus, Berlin; †Department of Orthopedics, Klini-
kum Buch, Berlin; #GBF, Braunschweig, Germany
Aim In chronic joint diseases, homeostasis of the cartilage
is disturbed. Synovial tissue expresses signs of inflamma-
tion and cartilage breaks down in a more or less severe
extent, depending on the quality of inflammation and dis-
ease. In search for possible regulatory factors of joint
homeostasis, factors of the TGF- family and their recep-
tors were comparatively studied in different chronic and
acute joint diseases and effects were analyzed in in vitro
and in vivo cultures of chondrocytes and tissue engineered
cartilage.
Methods Synovial tissue from osteoarthritis, rheumatoid
arthritis, meniscal injuries and normal joints was analyzed
for expression of TGF-1, -2, BMP-1, -2, -4, -5, -6, -7,
GDF-5, BMP-RIA, -RIB and RII by semiquantitative PCR
and compared to markers of inflammation (IL-1, TNF-a)
and destruction (MMP-1, MMP-3). Identification of produc-
ing cells was performed by in situ hybridization. Cultivated
chondrocytes were analyzed for expression of different
BMPs, BMP-receptors and differentiation markers. Artificial
cartilage was engineered with primary BMP-transgenic
chondrocytes and expression of several marker genes as
well as morphological studies were performed in vitro and
after implantation into nude mice.
Results BMPs were found to be expressed in adult syno-
vial tissue by PCR and in situ hybridization. Specific BMPs
like GDF-5, BMP-4 and -5 were down-regulated in parallel
with an increase of markers of inflammation and destruc-
tion. For BMP-5, a differential decrease was found, possibly
depending on the stage of chronicity or kind of joint
disease. In contrast, BMP-1, -2, -6, TGF- and BMP-
receptors did not present any significant differential expres-
sion. Using different BMPs as transgenes in primary
chondrocyte cultures, BMP-7 was favorable compared to
GDF-5 or BMP-2 in induction of collagen type II upregula-
tion. Furthermore, implanted tissue engineered cartilage
transgenic for BMP-7 suppressed inflammatory infiltrative
reactions of the surrounding connective tissue.
Conclusion In summary, these data underline an import-
ant role of specific BMPs and related factors for the
homeostasis of joint tissues. These factors are expressed
by synovial cells and may therefore be considered as
nutritive regulators. The decreased expression in inflamed
tissue suggests a deregulation which may contribute to the
progressive break down of cartilage. The antiinflamma-
tory and antiinvasive effects demonstrated in in vivo
experiments underline the potential of these factors as
therapeutic agents in chronic destructive joint diseases.
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Although the development of osteoarthritis (OA) is closely
associated with aging, the mechanism for this association
is not clear. An age-related decline in the response togrowth factor stimulation could play an important role. The
purpose of this study was to test the hypothesis that, with
increasing age, chondrocytes have a reduced response to
IGF-I stimulation and this decrease would remain signifi-
cant when controlling for potential effects of OA. Chondro-
cytes were isolated from knee cartilage of young (6–11
years), middle-aged (11–16 years), and older adult (>16
years) cynomolgus monkeys. These animals develop natu-
rally occurring OA which mimics the human disease includ-
ing the relationship between aging and the development of
OA. Each joint was scored on a scale of 0–7 for histological
OA. Cartilage samples from 27 monkeys ranging in age
from 6.7–26 years (mean 15.2±5.8) and OA scores of 0–7
(mean 2±1.3) were analyzed. Response to stimulation with
100 ng/ml IGF-I was determined in serum-free alginate
cultured cells as % of unstimulated controls by 35SO4
incorporation (proteoglycan synthesis) and 3H-proline
incorporation (collagen/protein synthesis) normalized for
cell numbers by measuring total DNA. Using multiple linear
regression analysis, a significant decline in IGF-I stimulated
35SO4 incorporation was noted with increasing age (relative
effect of −4.21±0.96; P=0.0001) which means a 4.21%
decline per year of age from 6.7 to 26 years. A significant
decline in response was also noted with increasing OA
score (−6.39±3.2; P=0.046). The effect of age was signifi-
cant when controlling for the effect of OA (−3.81±0.93;
P=0.0001) but the effect of OA was not significant when
controlling for age (−4.86±2.9; P=0.1). In parallel studies,
chondrocytes were stimulated with des(1–3) IGF-I which
has markedly reduced affinity for IGF binding proteins
(IGFBPs) to determine if the reduced IGF-I response may
be attributed to increased binding protein production. Simi-
lar to IGF-I, there was a reduced response to des(1–3)
IGF-I with increasing age (−3.82±1.32; P=0.007) but
unlike IGF-I, there was no effect of OA score on response
to des(1–3) IGF-I (+3.57±4.3). Similar results were
obtained using 3H-proline incorporation as the measure of
IGF response. These results clearly demonstrate an age-
related decline in the chondrocyte response to IGF-I
in animals which develop OA and confirm a reduced
response to IGF-I in chondrocytes from OA cartilage.
The results using des(1–3) IGF-I suggest that there is a
different mechanism in aging and OA. The reduced
response to intact IGF-I but not des(1–3) IGF-I in OA cells
is consistent with recent studies suggesting that OA cells
have an increased production of inhibitory IGFBPs. Since
the cells from older animals had a reduced response
to both forms of IGF-I, changes in IGFBPs alone are
unlikely to be responsible and suggest changes in IGF
receptors or, more likely, alterations in intracellular signal
transduction.EPIDERMAL GROWTH FACTOR-LIKE REPEATS OF
VERSICAN ENHANCES CHONDROCYTE
PROLIFERATION AND REGULATES CHONDROCYTE
MORPHOGENESIS
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College Health Science Centre and Department of
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Versican is a large chondroitin sulfate proteoglycan and is
highly expressed in zones of developing tissues. It contains
two EGF repeats in the G3 domain. We have previously
demonstrated that versican enhances NIH3T3 fibroblast
Osteoarthritis and Cartilage Vol. 8 No. 2 159proliferation (JBC, 273, 21342-21352, 1998) and inhibits
mesenchymal chondrogenesis (JBC, 273, 33054-33063,
1998). Here, we designed experiments to investigate the
role of versican in chondrocyte growth and morphogenesis.
We studied the expression of versican in suspension and
fibroblast-like chondrocytes. We also transfected a number
of constructs containing different domains of versican into
suspension and fibroblast-like chondrocytes. We observed
that versican expression was significantly enhanced when
chondrocytes dedifferentiated into fibroblast-like chondro-
cytes. Expression of versican enhanced the proliferation of
fibroblast-like chondrocytes, and this occurred through the
EGF-like motifs of versican. Antisense to versican also
inhibited chondrocyte proliferation. Expression of a mini-
versican construct stimulated chondrocyte elongation,
while antisense to versican inhibited this process. A mutant
mini-versican lacking two EGF-like motifs (versicanEGF)
played a dominant negative effect on the morphogenesis of
fibroblast-like chondrocytes; it reversed the process ofchondrocyte dedifferentiation (redifferentiation). While ver-
sican expression promoted chondrocyte dedifferentiation
and elongation, expression of the mutant mini-versican
inhibited chondrocyte dedifferentiation and stimulated cell
rounding up. As a result, the redifferentiated chondrocytes
expressed significantly higher levels of aggrecan, type II
collagen and link protein, characteristics of normal
chondrocytes. Furthermore, we demonstrated that a
mutant G3 construct (the G3 domain lacking the two
EGF-like motifs or G3EGF) also imparted a dominant
negative effect on fibroblast-like chondrocyte redifferenti-
ation. This changed morphology was associated with cell
division, since cell division in the G3EGF-transfected
chondrocytes was inhibited resulted in multinucleation. We
further demonstrated that the mechanism associated with
morphogenesis and multinucleation was due to mis-
assembly of actin filaments. Our studies indicated that
different domains of versican have different functions in
mediating cell activities.
